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ABSTRACT OF DISSERTATION

INVESTIGATING THE EFFICACY OF VOCAL FUNCTION EXERCISES
(VFE) IN IMPROVING VOCAL FUNCTION IN ADULTS IRRADIATED
FOR LARYNGEAL CANCERS: A THREE PART DISSERTATION

Deterioration in voice quality following radiation therapy for the treatment of
laryngeal cancers (LC) is well documented in literature. The majority of studies show that
these voice problems are long term and in some cases permanent. Deterioration in voice
quality, especially over a period of time could lead to significant communication
difficulties in daily life or in some cases could even result in loss of profession. Despite
the negative effects of radiation therapy on voice quality being well documented, few
studies have focused on the efficacy of voice therapy in the irradiated LC population.
The purpose of this study was to investigate the efficacy of a well researched,
evidence based voice therapy approach, known as Vocal Function Exercises (VFEs) in
improving vocal function in patients who have been irradiated for LCs. The present study
conducted in three systematic stages with distinct and related study aims. The first
involved characterizing the head and neck cancer treatment seeking population at the
University of Kentucky (UK). Stage 2 involved characterizing vocal function following
irradiation for LC using a multidimensional assessment approach. Stage 3 was a phase 2
clinical trial aimed at treating these deficits in vocal function identified through stage 2
using a systematic evidence based voice therapy approach, Vocal Function Exercises. For
the phase 2 clinical trial, the comparison group received vocal hygiene (VH) counseling.
Observations from stage 1 showed that majority of patients from the treatment
seeking population at UK between a 3 year time period from 2008 to 2010 were
diagnosed with laryngeal cancers and were treated with chemoradiation therapy. Stage 2
demonstrated a multidimensional deterioration in vocal function following radiation
therapy for laryngeal cancers. Stage 3 demonstrated a significant improvement in vocal
function across the primary outcome measure (Voice Handicap Index) as a result of
VFE+VH. Improvements were also seen in select parameters across the five domains of

voice assessment in the VFE group. No significant improvements were observed in the vocal
hygiene group in any parameters in each domain of voice assessment.
Our study demonstrated adults irradiated for laryngeal cancers demonstrated a multidimensional deterioration of vocal function. These changes were long term since study
participants were 2- 7 years post radiation therapy. Implementation of VFE+VH demonstrated a
significant improvement in voice related quality of life and select parameters across the five
domains of voice assessment. The present study demonstrated promising preliminary evidence
for the use of VFE+VH to improve vocal function in patients irradiated for laryngeal cancers.
Key words: Laryngeal cancer, Radiation therapy, Vocal Function Exercises, vocal hygiene,
Appalachian Kentucky
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CHAPTER 1: INTRODUCTION
The curative role of radiation therapy (XRT) in the treatment of laryngeal cancers is
well documented. Early laryngeal cancers can be treated with XRT alone, while advanced
laryngeal cancers are often treated with a combination of chemotherapy and radiation therapy.1-3
Radiation therapy, however, was not always the primary mode of choice for treatment of
laryngeal cancers. A shift in the treatment trends of laryngeal cancers occurred in the early 1990s
following completion of a clinical trial conducted by the Department of Veteran’s Affairs (VA)
Laryngeal Cancer Study Group. The clinical trial completed by the VA showed comparable
survival rates between primary chemoradiation therapy and total laryngectomy for the treatment
of laryngeal cancers.4 Prior to 1990, advanced laryngeal cancers were primarily treated with
surgical resection which involved complete removal of the larynx, also known as total
laryngectomy. If the extent of the cancer warranted further intervention, patients were treated
with radiation therapy after surgery. A total laryngectomy is associated with significant morbidity
since it results in the alteration of a patient’s anatomy such that breathing subsequently takes
place through a permanent tracheostoma. Undergoing total laryngectomy also means losing one’s
natural source of voicing, the larynx itself. Consequently, following results from the VA study
and a 10-year follow-up study which supported the initial findings,5 an increasing number of
patients with laryngeal cancers have been treated primarily with radiation therapy, with or
without chemotherapy, with the intent of preserving laryngeal structure and function.
Preservation of structure through radiation therapy, with or without chemotherapy for
treatment of laryngeal cancers has not necessarily led to preservation of function. A number of
studies have documented long-term voice and swallowing problems post-radiation, consequent to
radiation-related toxicity. These prolonged, and in some cases permanent, post-radiation voice
and swallowing problems are indicators that preserving laryngeal structure does not translate to
preserving laryngeal function. In fact, collateral damage to the laryngeal, oral, and oropharyngeal
structures caused by radiation toxicity absent chemotherapy is a well-documented clinical entity.61
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Radiation damage to the larynx results in edematous and dehydrated tissues, leading to

excessive compensatory compression of laryngeal structures during phonation, thus affecting
vocal fold vibratory characteristics and impacting perceptual vocal quality.8,10-12
Another characteristic feature of radiation toxicity is delayed injury. Consequently, in
addition to acute changes to the laryngeal mechanism, ongoing damage occurs as a result of
radiation toxicity. Acute and long-term deterioration of voice quality post-radiation may lead to
significant communication deficits in daily life or in some cases may result in loss of livelihood.
Therefore, post-radiation therapy voice rehabilitation is important. Unfortunately, there is a dearth
of knowledge with respect to voice rehabilitation in the irradiated population. Only four studies
have investigated the efficacy of voice therapy in post-radiation laryngeal cancer patients, with no
recommended standardized treatment.13-16 In these existing studies, vocal hygiene (VH)
counseling is an approach that is commonly recommended.13-17 However, results of outcomes
research related to VH demonstrate that this therapy approach may be more effective when
coupled with a more exercise-intensive physiologic voice therapy approach.18-20 The Vocal
Function Exercise (VFE) program is one such evidence-based physiologic approach to voice
therapy.19,21
VFEs include a series of isometric and endurance-based exercises aimed at strengthening
laryngeal musculature, improving vocal fold vibratory characteristics, and balancing the three
sub-systems of voice production, respiration, phonation and resonance.22 Although VFEs have
been employed successfully in treating a variety of voice disorders, the efficacy of this approach
for improving vocal function in patients who have undergone XRT for laryngeal cancer has not
been established.18,19,22,23 The overall objective of this study was to investigate the efficacy of
VFEs to improve vocal function in adults irradiated for laryngeal cancers. This investigation was
performed in three systematic stages, which are described briefly in the next section.
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Dissertation Stages
Stage I primary objective
This stage involved characterizing the trends in head and neck cancers among a treatment-seeking
population at the University of Kentucky Otolaryngology clinic.
Stage I rationale: Rehabilitation following laryngeal cancers is especially relevant to the study
population in the present dissertation since all participants of the study were residents of
Kentucky. Laryngeal cancers are a subgroup of head and neck cancers. At 13.5%,24,25 Kentucky
has the highest incidence rate for head and neck cancers in the United States (U.S.).25,26 The
association between smoking and head and neck cancer risk is strongest for the laryngeal cancer
subgroup.27 Furthermore, while the overall incidence of head and neck cancers (HNC) continues
to decrease throughout the U.S., Kentucky has alarmingly shown a rise of 1.6% in the incidence
of HNCs since 2007.24 The high incidence of HNCs in Kentucky can be linked to the increased
prevalence of tobacco use in the state, since 90% of HNCs occur after prolonged exposure to
tobacco and/or ethanol.27,28 Unfortunately, within the U.S., Kentucky leads in smoking prevalence
rates.29 Within Kentucky, smoking rates are higher for Appalachian Kentucky (rural Eastern
Kentucky) as compared to the urban regions within Kentucky.29 Within the subgroups of all
HNCs, laryngeal cancers show the highest incidence rates (5.7 per 100,000) in Kentucky.24 As a
result, large numbers of individuals within the state receive treatment for laryngeal cancers. This
initial stage of research helped in identifying my target population, specifically patients who have
been treated with radiation therapy for laryngeal cancers. Individuals identified through stage I
were subsequently recruited for stage II. The following section briefly describes the primary
objective and rationale for stage II.
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Stage II primary objective
The primary objective of stage II was to establish the effects of radiation therapy on vocal
function in adults irradiated for laryngeal cancers, as assessed by the five domains of voice
assessment.
Stage II rationale: A number of studies have documented the undesirable effects of radiation on
vocal function.1,9,30-32 However, these studies used limited outcome measures to assess voice
production following radiation therapy. Normal vocal function or voice production is dependent
on an interaction of physiological and psychosocial factors. Consequently, vocal function is best
assessed with measures that account for both physiological as well as psychosocial measures
using a multidimensional voice assessment battery, which utilizes the five domains of voice
assessment.33 These measures include stroboscopic (laryngeal visualization), acoustic,
aerodynamic, patient self-report and auditory-perceptual parameters.33 To this end, assessment of
vocal function in my study population was assessed using this multidimensional assessment
battery in patients following XRT for laryngeal cancers. Vocal function of irradiated individuals
was also compared to a control group of individuals who were matched in terms of age, sex and
smoking habits. This stage was meant to identify the nature of voice problems faced by patients
irradiated for laryngeal cancers and also establish a patient’s perspective on the impact of these
voice problems on the individual. Results from stage II highlighted the deleterious effects of
radiation therapy on vocal function, thus creating a lens through which to investigate optimal
rehabilitation techniques.
Stage III primary objective
The primary objective of stage III was to investigate the efficacy of Vocal Function Exercises
(VFE) in improving voice production in adults radiated for laryngeal cancers, as compared to
vocal hygiene therapy. This stage was designed as a pilot study to collect preliminary data on the
efficacy of VFEs in the irradiated population to support a possible future multi-center trial.
4

Rationale for Stage III: Despite post-radiation voice problems being well-documented in
literature, only four studies have investigated the efficacy of voice therapy in the laryngeal cancer
population.13-17 The voice therapy interventions across all four studies, however, were varied and
not specified. Central to treatment approaches across all studies was vocal hygiene counseling.
The outcomes research on vocal hygiene as a sole method of treatment, however, is not
favorable.19,20,34 In fact, previous studies have shown vocal hygiene works best when coupled
with a more exercise-intensive physiologic voice therapy approach.19,20,34 The Vocal Function
Exercise (VFE) program is one such prescriptive evidence based physiologic voice therapy
approach and has been successful in treating various voice pathologies in schoolteachers, singers
and the aging voice.18,23,35,36 Given the efficacy of VFEs in treating various voice disorders, this
therapy approach was chosen as the experimental treatment modality for adults who experienced
voice problems as a result of radiation therapy for the treatment of their laryngeal cancer.
This chapter was intended to provide the reader with an overview of the significance and
rationale for the three stages of this dissertation. The next chapter provides a more detailed review
of literature pertinent to the main study objective; investigating the efficacy of VFEs in improving
voice quality in adults irradiated for laryngeal cancers.
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CHAPTER 2: REVIEW OF LITERATURE
This chapter reviews pertinent literature in the domains of radiation therapy for treatment
of laryngeal cancers. First, laryngeal cancer trends in the United States are discussed. The second
section will review literature pertinent to voice problems following radiation therapy. The third
section will briefly discuss the available evidence on voice rehabilitation following radiation
therapy for laryngeal cancers. The fourth section will discuss the rationale for choosing Vocal
Function Exercises (VFE) as the treatment for voice problems following radiation therapy for
laryngeal cancers.
LARYNGEAL CANCER
Laryngeal cancers are a sub-group of head and neck cancers that originate in one or more
sub-sites of the larynx. The number of estimated new cases and deaths from laryngeal cancer in
the United States in 2014 were 12,630 and 3,610 respectively.37 For the purposes of clinical
staging, the larynx is divided into three sub-sites; glottis, supraglottis and subglottis.38 The glottis
consists of the superior and inferior aspects of the true vocal folds, as well the anterior and
posterior commissures.38 The supraglottis is comprised of the false vocal folds, arytenoids,
aryepiglottic folds and epiglottis.38 The subglottis is comprised of the area from the lower
boundary of the glottis to the lower margin of the cricoid cartilage.38 The most common
histological type of laryngeal cancer is squamous cell carcinoma, which is associated with more
than 90% of all laryngeal cancers.27,28
Depending on the tumor stage and sub-site, laryngeal cancers can be treated with surgery
alone, radiation therapy (XRT) alone, a combination of chemotherapy and radiation therapy or a
combination of all of the above modalities. For the purpose of this dissertation, I focus on the role
of XRT in the treatment of laryngeal cancers and its effects on laryngeal tissues and vocal
function following completion of treatment.
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Radiation therapy modalities used in the treatment of laryngeal cancers
Radiation therapy for patients with laryngeal cancers is traditionally delivered via two
modalities; wide field radiation therapy and narrow field radiation therapy. As the names suggest,
wide field radiation therapy is delivered over a wide field of tissues, which in the case of a larynx
cancer patient may include the primary site and neck.3 Narrow field radiation therapy, also known
as intensity modulated radiation therapy (IMRT) delivers the required radiation dose in a
concentrated area.1,39 Wide field radiation therapy is commonly used in the treatment of advanced
laryngeal cancers since these tumors are often large and include cervical lymph nodes.39 IMRT is
commonly used to treat early glottic cancers as it is successful in concentrating the radiation
beam on smaller areas.39 Wide field radiation therapy causes greater collateral damage of
surrounding tissues as compared to narrow field radiation therapy.39,40 Radiation dosage typically
ranges from 60-70 Gy and is administered for 5-7 weeks.41,42
Effects of radiation therapy on voice quality
Since the 1990s, an increasing number of patients are being treated with XRT with the
intent of preservation of laryngeal structure and function.3 However, with increasing outcomes
research in the area of voice and swallowing rehabilitation, it is apparent that preservation of
structure after radiation therapy does not necessarily translate into preservation of
function.9,12,15,30,43-45 The following section describes the effects of radiation toxicity on vocal
function.
Voice problems following radiation therapy
There are a number of studies that have documented the effects of radiation on voice
quality. Since a majority of these studies were retrospective chart reviews, it was interesting to
note that these studies frequently reported disordered voice status and findings years after
radiation therapy was completed. These findings are a strong indicator of the prolonged
7

detrimental effects of XRT on vocal function. Normal vocal function is an interaction of
physiological and psychosocial factors.46 Physiologically, normal voice production is dependent
on a balanced interaction of respiration, phonation and resonance.21 The psychosocial aspect of
voice production is dependent on the individual’s voice use in his or her environment with
regards to activities of daily living and professional demands.47 Due to its multifactorial nature,
voice production is best evaluated using a multidimensional voice assessment battery, which
encompasses physiological and psychosocial factors of voice production. To this end, research on
voice outcomes suggests that voice production or vocal function is best assessed through the five
domains of voice assessment which includes visual perceptual parameters (laryngeal imaging),
auditory-perceptual parameters (clinician’s perception of voice quality), patient perception
(voice-related quality of life), acoustic analysis and aerodynamic analysis.33 Studies that have
investigated voice outcomes following radiation therapy have used one or more, but not all
recommended parameters from the five domains of voice assessment. The following section
provides the reader with a brief description of procedures contained within the five domains of
voice assessment. The section has a special focus on select parameters in each domain that were
chosen as assessment parameters for stage 2 and stage 3 of the present dissertation.
Domain 1: Auditory Perceptual Measures
Ray Kent said “the ear is an essential tool of the speech-language pathologist”.48
Auditory perceptual assessment of voice quality essentially involves a clinician rating a patient’s
voice disorder or dysphonia using various descriptive parameters. These parameters can be
general, for example, “patient presents with moderate dysphonia” or can be more specific to
features heard in patient’s voice, for example, “patient presents with a moderate degree of
roughness, and mild breathiness and strain”. An auditory-perceptual evaluation is one of the most
traditional and widely used methods of voice assessment. However, as is evident from these
variable descriptions above, speech-language pathologists (SLPs) are recommended to use
8

standardized assessments for auditory perceptual evaluation of voice to ensure consistency
amongst clinicians and in turn strengthening external validity. There are various scales that are
utilized in the auditory perceptual evaluation of voice but few that have been standardized. Two
of the most widely used scales for voice assessment are the GRBAS 49 and Consensus AuditoryPerceptual Evaluation of Voice (CAPE-V).50 The GRBAS scale is easy to administer and was
developed to rate vocal quality within five perceptual categories: overall grade (G), roughness
(R), breathiness (B), asthenia (A), and strain (S). However, its sensitivity in detecting vocal
alterations has been demonstrated to be lower than that observed with CAPE-V, possibly because
GRBAS is an ordinal scale with only three alternatives (mild, moderate, and severe). The
GRBAS has also been shown to be less sensitive than CAPE-V to evaluate subtle differences in
voice quality.51 The use of the CAPE-V has been highly recommended and SLPs are being
increasingly being encouraged to use the CAPE-V. Since its inception, the CAPE-V was devised
to promote the standardization of evaluating and documenting auditory-perceptual judgements of
voice quality. 52,53 The CAPE-V assesses perceptual vocal parameters which are (a) Overall
Severity; (b) Roughness; (c) Breathiness; (d) Strain; (e) Pitch; and (f) Loudness. The CAPE-V
displays each parameter accompanied by a 100- millimeter line forming a visual analog scale
(VAS). Please see Appendix 1 for CAPE-V form. Judgments are marked on each scale on the
CAPE-V: “MI” refers to "mildly deviant," “MO” refers to “moderately deviant,” and “SE” refers
to "severely deviant." Its greater sensitivity in detecting small differences in the voice, as
compared with GRBAS, has been attributed to the use of its visual analog scale. 50,54,55 A slightly
improved rater reliability using the CAPE-V to make perceptual judgments of voice quality, in
comparison with the GRBAS scale, has also been reported.51 The present dissertation study
utilized CAPE-V scores as the outcome measure for the auditory-perceptual domain given its
standardization, high reliability and its high recommendation to being the auditory perceptual
scale of choice. The following section gives us a brief description of the reliability and validity
measures for the CAPE-V.
9

CAPE-V: The CAPE-V has demonstrated criterion validity and both intra- and interrater
reliability. Intrarater reliability using Pearson’s r ranged from .35 to .82 depending on the voice
quality measured.54 Strain had the lowest reliability and breathiness had the highest reliability.
Interrater reliability was measured with Shout-Fleiss intraclass correlation coefficients (ICC) and
ranged from .28 to .76 with pitch having the lowest reliability and overall severity having the
highest reliability. Zraick et al., reported the intra and interrater reliability of this instrument.53
Pearson’s r for intrarater reliability revealed the following: Overall severity .57, Roughness .77,
Breathiness .82, Strain .35, Loudness .78, Pitch .64. Interrater reliability using Shout-Fleiss
intraclass correlation coefficients revealed: Overall severity .76, Roughness .62, Breathiness .60,
Strain .56, Loudness .54, Pitch .28.53
Domain 2: Patient self assessment
Voice disorders can have a significant effect on quality of life.56 Patient self assessment
scales for voice disorders evaluate the impact of a voice disorder on a person’s quality of life.
There are several scales available for patient self assessment in the voice disordered population.56
However, a previous review article rated the Voice Handicap Index (VHI) and the Voice-Related
Quality of Life (V-RQOL) as the psychometrically strongest of the existing measures.57 The
Voice Handicap Index (VHI), developed by Jacobson et al.,47 is a 30-item questionnaire designed
to assess the patient’s perceived impact of a voice disorder in three domains: physical, emotional,
and social. The Voice related Quality of Life (V-RQOL) 46 is a 10 item questionnaire which also
probes patient perceived difficulty with their voice in physical and socio-emotional domains.
Internal consistency of the V-RQOL has been demonstrated to be high at Cronbach’s alpha of
0.89.46 VHI and VRQOL scores have been demonstrated to be highly correlated.58 For the
purpose of this dissertation, the VHI was chosen as the outcome measure of choice since it has
been used in other studies investigating the efficacy of voice therapy in the irradiated
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population.15,16 Below is a brief description of reliability and validity measures directly related to
VHI scores.
Voice Handicap Index (VHI): Criterion validity was established by comparing the VHI scores
with patient-perceived severity of their voice. Test re-test reliability for the three domains was
Functional (r = 0.86), Physical (r = 0.86), Emotional (r = 0.92), and Total (r = 0.92). The
minimum detectable change in the total score of 18 points was determined to indicate a clinically
significant change in pre- and post-therapy measures.47
Domain 3: Acoustic analysis
An acoustic analysis of voice production offers the clinician an instrumental objective
analysis of a patient’s voice. There are a number of acoustic measures available. However, for the
purpose of this section we will review three common measures used across studies and which
were used as outcome measures for stages 2 and 3 of the present dissertation study. It should be
noted that frequency and intensity based-measures do have inherent limitations. However they
continue to be used as outcome measures in studies because they can provide change scores
demonstrating post-therapeutic voice changes.
These limitations are related to their reliance on the accurate tracking of fundamental
frequency during voice production. These limitations can be overcome by methods that rely on
cepstral analysis of voice which is in turn is not dependent on fundamental frequency.59 As a
result, commonly used perturbation and noise measures (jitter, shimmer, noise-to-harmonic ratio)
are used in the analysis of sustained vowels,60 and cepstral measures are used in the analysis of
connected speech and highly disordered voices.60 Below is a brief description reliability and
validity of acoustic measures used in the present dissertation study.
Perturbation measures: Jitter is the short-term cycle-to-cycle variation in frequency in a voice
sample, whereas shimmer is the short-term cycle-to-cycle variation in amplitude. Both of these
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measures failed to demonstrate strong reliability because of differences in extraction methods
across systems and because highly dysphonic voice signals decrease reliability. 61 These measures
are reliable for sustained vowels, but not for connected speech and highly dysphonic voices.60 To
overcome this barrier, the present study also included the Cepstral Speech Index of Dysphonia
which accounts for aperiodicity and connected speech.60
Noise measures: Harmonics-to-Noise Ratio (HNR) is based on the premise that normal vocal
production consists of a strong harmonic component with a smaller degree of aperiodic noise .62
Voices which carry a stronger harmonic component compared to the noise component should
yield better perceptual voice quality. HNR validity has been examined by comparing HNR
results to auditory-perceptual ratings of voice. Yumoto et al. 63 found a significant correlation (r =
0.81) between HNR results and perceptual ratings. The reliability of HNR for repeated measures
of subjects’ voices was examined by Bough et al.64 The study examined the intra- and inter-day
reliability for measures of HNR. Intraclass Correlation Coefficients for HNR measures taken
within a single day ranged from 0.93 to 0.98. Coefficients for measures taken across a series of
days ranged from 0.761 to 0.86. 64 The present study used the Noise to Harmonics ratio which is
an inverse ratio of the HNR and has been found to be highly reliable as well.65,66
Cepstral Speech Index of Dysphonia (CSID): The cepstrum has been described by Noll 67 as a
Fourier transform of the logarithm power spectrum. 65 The principal advantage of spectral
analysis methods is that estimates of aperiodicity and/or additive noise may be achieved without
the identification of cycle boundaries.60 A study by Awan, et.al. demonstrated that acoustic
estimates of dysphonia severity can be achieved in both continuous speech and vowel contexts
using a model incorporating spectral/cepstral measures. The study also demonstrated a strong
relationship between perceptual (CAPE-V measures) and acoustic estimates of dysphonia using
cepstral analysis (R=0.96, R=0.81).60
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Domain 4: Aerodynamic Measures
Aerodynamic measurement of voice production concerns measurements of air pressures
and air flows that are meaningful in clinical diagnosis and treatment. These measures may help
interpret the valving activity of the larynx. The vocal tract is an aerodynamic sound generator and
resonator system. Variations in the flow of air through it reflect changes in the “manner” of
consonant & vowel articulations. Evaluation of airflow can provide insight into speech or voice
system dysfunction and efficiency.65 The aerodynamic measures used for stages 2 and 3 of the
present dissertation are described below with their reliability and validity measures.
Subglottic pressure (PSub): Psub is a measure of air pressure beneath the vocal folds necessary
to overcome the resistance of the approximated folds to initiate and maintain phonation.65
Estimated subglottic pressure is taken from a pressure sensing tube placed in the mouth during
production of a pressure consonant, typically /p/. Because the pressure in the lungs rapidly is
transmitted to the lips a useful estimate of the subglottic pressure can be obtained. 65 Subglottic
pressure has established criterion validity when compared to tracheal puncture. Direct measures
of subglottic pressure and indirect estimated subglottic pressure at the lips have been
demonstrated to have comparable results.65
Mean airflow rate: The mean airflow rate of a speech sample refers to the average rate of
airflow during a given production.65 The mean airflow rate of a speech sample refers to the
average rate of airflow during a given production.65 This measure is commonly taken using an
anesthesia-type mask placed over the nose and mouth so that oral airflow during vowel
production is passed through a pneumotachometer which senses pressure changes and
mathematically converts these into airflow rates.
Laryngeal Airway Resistance: To calculate mean estimated subglottic pressure and mean
airflow rate, syllable trains of a pressure consonant and a vowel may be used, usually /pa/.
Pressure is sensed during the consonant and airflow is transduced during the vowel. These
measures may be interpreted individually or as a ratio of pressure to flow, termed laryngeal
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airway resistance. Smitheran and Hixon 68 calculated the reliability with intraclass correlation
cofficients of laryngeal airway resistance across three sessions using normal participants to be
0.96.
Domain 5: Laryngeal imaging or Visual Perceptual Measures
Laryngeal stroboscopy is a commonly used clinical method to assess vocal fold vibration.
Another visualization method that is gaining popularity is high speed laryngeal imaging since it
helps overcome the instrumental limitations of laryngeal stroboscopy.69 Although high speed
laryngeal imaging is gaining popularity as a method of assessing vocal fold vibration, it is not
readily available in a number of clinical settings. As a result, its clinical utility continues to be
under investigation. Stroboscopy and high speed laryngeal imaging permit direct visualization of
the vibrating vocal folds, allowing detailed assessment of laryngeal structure and function.70
Because of the large number of vocal fold vibration parameters and somewhat subjective nature
of interpreting visual examinations, these measures do hold reliability concerns. Some of these
concerns include examiner bias, clinician training, and lack of standardization in rating
parameters. Quantification of imaging parameters has not gained universal acceptance clinically
because of its cumbersome nature.71,72 There are, however, many rating scales that may be used to
guide interpretation of imaging parameters.70,73-75 There is some reliability data in interpretation
of imaging parameters which supports its use. Intrajudge reliability for overall ratings has been
demonstrated to range from 0.31 to 0.97,73 and interjudge reliability ranged from 0.75 to 0.98.76
Since the previous section has informed the reader on select parameters and their role in
the assessment of voice disorders, the next section provides the reader with a brief description of
study findings across the five domains of post-radiation voice assessment for patients treated for
laryngeal cancers.
Stroboscopic findings: In a detailed study performed by Lehman et al (1988),77 significant
abnormalities were seen on stroboscopic analysis in patients irradiated for stage I glottic cancers.
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Around 60% of patients showed irregular vocal fold closure, 65% showed increased supraglottic
activity, 85% showed irregular vibratory margins, 80% showed shorter phase closure, and 85%
showed irregular phase symmetry. The stroboscopic finding which was consistent across the
group was decreased vibratory amplitude not only on the treated vocal fold but also on the nondiseased fold. These findings were consistent with those in a study by McGuirt et al. (1994)12 and
Wedman et.al78 that reported decreased mucosal wave on both the affected and non-diseased fold.
In addition, subjects showed signs of muscle tension dysphonia, ventricular phonation, and partial
antero-posterior compression.
Aerodynamic measures: McGuirt et al. (1994)12 revealed mean laryngeal airway resistance
(LAR) values 4.5 times greater than normal values (mean=177cmH2O/L/s) in patients who had
been irradiated for T1a glottic cancer. These LAR values were comparable to those in a study by
Dworkin (1997)30 who found that none of 12 irradiated patients attained normal aerodynamic
measures. Increased airflow rates in patients who had undergone radiotherapy (n=6) were also
observed in a study by Tamura (2003)79 in which mean airflow rates of 165 cc/s were measured.
Increased aerodynamic resistance values reflect the signs of supraglottic hyperfunction seen
stroboscopically and are also indicative of issues with glottal valving during phonation.
Acoustic measures: A majority of studies showed that radiation therapy had a negative impact on
voice production demonstrated by increased perturbation and noise measures. Voice production
was gradually found to improve over 3-6 months post radiotherapy. However, none of the posttreatment values were within the normal range. 78-80
Auditory-Perceptual findings: Auditory-perceptual findings from previous studies report varied
vocal symptoms. Perceptually patients often present with hoarseness, decreased volume,
increased strain and persistent voice changes.8,13,81
Voice-related quality of life: A recent study by Karlsson, et al. (2016) 17 that investigated voicerelated quality of life in patients with early and advanced laryngeal cancers revealed no significant
differences between pre-radiation and post-radiation scores one year after completion of treatment.
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These results indicate that the deterioration in voice quality perceived by the patient as a result of
laryngeal cancer did not improve after completion of treatment to eliminate laryngeal cancer.17 A
study that investigated voice problems as a result of radiation for early glottic cancers
demonstrated that 87.8% of the patients sampled reported their voice as being abnormal, ranging
from slight to moderate dysfunction.82 From the above clinical findings, it is established that
patients irradiated for laryngeal cancers experience long-term voice problems that affect quality of
life. The next section provides a brief description of voice intervention studies in the irradiated
laryngeal cancer population.
Voice rehabilitation following radiation therapy for laryngeal cancers
Only four studies document the application of voice therapy for individuals irradiated for
laryngeal cancers.13-16 Two studies by Van Gogh et. al15,16 focused on voice rehabilitation in
patients following irradiation for early glottic cancers, and studies by Tuomi et.al14 and Bergstorm
et. al13 included patients who had received XRT for early and advanced laryngeal cancers across
all laryngeal sub-sites.
Van Gogh et.al, reported improvements in Voice Handicap Index (VHI) scores for
patients irradiated for early glottic cancers following voice therapy interventions.16 The second
study by Van Gogh et.al15 followed patients who had received voice therapy following irradiation
for early glottic cancer for one year post-treatment to investigate if the effects of voice therapy
were maintained. Their study demonstrated that beneficial short-term effect on the mean VHI,
percent jitter, and shimmer were maintained after more than one year of follow-up. Voice
rehabilitation in both studies included vocal hygiene with non-specified voice and breathing
exercises. The control group in both studies did not receive any voice treatment.
Results from the study by Tuomi et.al14 showed that patients who received vocal
rehabilitation experienced improved self-rated vocal function after rehabilitation. Patients with
supraglottic tumors who received voice rehabilitation had statistically significant improvements in
voice quality and self-rated vocal function, whereas the control group did not. In a randomized
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controlled trial, Bergstorm et.al,13 reported that subjects receiving voice rehabilitation showed no
functional decline in vocal roughness 6-12 months post radiation therapy and perceived their
voices to improve to a greater extent as a result of voice rehabilitation than the control group. In
both studies, the control group received voice education and vocal hygiene as an intervention. The
study by Bergstorm et.al described their voice rehabilitation intervention as a “structured hierarchy
consisting of both direct and indirect voice interventions, including tasks such as breathing,
relaxation, posture and specific physiology-targeted phonation exercises.”13 Tuomi et.al14 listed
their voice therapy activities hierarchically; however specific production tasks under each activity
were not specified.
From the four study results reported above, it appears as though voice therapy or voice
rehabilitation was beneficial in patients irradiated for both early as well as advanced laryngeal
cancers. However, none of the studies specified a systematic or consistent voice therapy approach
across all patients.
The present dissertation study was aimed at using an evidence- based prescriptive voice
therapy approach in individuals irradiated for laryngeal cancers. The next section focuses on the
rationale behind choosing Vocal Function Exercises as the experimental intervention method.

Rationale for choosing Vocal Function Exercises as choice of experimental intervention
There are a number of voice therapy methods or voice therapy orientations that have been
used over the years for the treatment of voice disorders.34,83 Based on a review article by Thomas
and Stemple,20 three primary orientations to the treatment of functional voice disorders have
emerged in literature; hygienic voice therapy, symptomatic voice therapy and physiologic voice
therapy. The following section provides the reader with a brief description of each of these voice
therapy orientations.
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Hygienic voice therapy: Hygienic voice therapy is based on the belief that many functional voice
disorders are caused and maintained by behaviors that can damage laryngeal structure and
function, and subsequently, eliminating these behaviors will result in improved vocal
performance.20 Often, hygienic voice therapy is a precursor in managing voice disorders and is
most effective when used in combination with other techniques.19,20,84,85 When compared to no
treatment at all, vocal hygiene has been proven to be effective in the management of voice
disorders;85,86 however in studies that compared vocal hygiene to other voice therapy
interventions such as Vocal Function Exercises and Resonant Voice Therapy,19,87-89 the consistent
finding across all of these studies was an improvement in voice quality when a more physiologic
approach was employed. Some authors describe vocal hygiene as an indirect method of voice
rehabilitation since it targets behaviors around voice use and not vocal physiology directly.86,88 It
is clear from these studies that while vocal hygiene is an important part of voice therapy, it is not
effective as a stand-alone mode of treatment and often more effective when coupled with a more
direct therapy approach.20 More specifically, when vocal hygiene education was compared to
voice therapy exercises in subjects irradiated for early glottic cancers, it was the voice therapy
exercise group that showed long term significant improvement in voice quality.15,16
Symptomatic voice therapy: Organized by Daniel Boone (1971), symptomatic voice therapy
operates on the basis that voice disorders are caused by functional misuse or abuse of vocal
components including respiration, pitch and loudness. Symptomatic voice therapy aims at
modifying these deviant vocal symptoms that are expressed as breathiness, low pitch, glottal fry
phonation, use of hard glottal attacks or using an inappropriate pitch in general.90,91 Various
facilitation techniques employed in symptomatic voice therapy are geared towards reducing or
eliminating these inappropriate components and promoting better voice production. Some studies
have described symptomatic voice therapy as a direct therapy method when compared to vocal
hygiene.92,93
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Physiologic voice therapy:

20,91

As the name suggests, this approach includes techniques that

directly involve altering and modifying the physiology of the voice-producing mechanisms.
Normal voice production is dependent upon a balance among the respiratory, phonatory and
resonance systems. This requires a relative balance among the airflow from the lungs, strength
and coordination of the intrinsic laryngeal muscles, and the structural and functional integrity of
the vocal tract and participating resonating cavities. In addition, the emphasis of physiologic
voice therapy is on maintaining the health of the vocal fold cover.91
Some of the most commonly used physiologic voice therapy approaches are implementation
of Vocal Function Exercises, Resonant Voice therapy and the Accent method of voice therapy.
The rationale behind these methods is described below in detail:
I)

Vocal Function Exercises:21 Vocal Function Exercises, first described by Barnes and
then further developed by Stemple20 are aimed at strengthening and rebalancing the
three sub-systems of voice production, namely respiration, phonation and resonance.
It is based on the principles of basic exercise physiology that state the role of
resistance and endurance exercises in improving muscle function and strength.94,95
The exercise program itself is comprised of a series of four exercises which include a
warm up exercise, stretching, contraction and increased resistance exercises. The
typical exercise program lasts for about 6-8 weeks depending upon patient progress.
The exercise program like any other program of the same nature involves repetitive
strengthening tasks, endurance tasks and relies heavily on patient compliance. Patient
progress and technique therefore need to be tracked carefully through the exercise
program. A number of studies have employed Vocal Function Exercises successfully
in the management of voice disorders, both organic and non-organic.19,20,22,23 A
number of outcomes studies have been reported that used VFEs across different highrisk populations such as singers and school teachers.
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II)

Resonant Voice Therapy (RVT): RVT was first described in literature by Arthur
Lessac and was developed further by Katherine Verdolini. Resonant voice is defined
as voice production involving oral vibratory sensations, usually on the anterior
alveolar ridge or higher in the face in the context of easy phonation.21 RVT is aimed
at maximizing voice production by achieving a strong and clean voice quality in the
presence of minimal vocal effort. This therapy method operates on the rationale that
minimizing vocal fold impact during voice production would minimize the likelihood
of vocal fold injury. Like VFEs, RVT too has been the subject of outcomes studies,
either as a stand-alone method, or in conjunction with other voice therapy methods.
19,89,96,97

III)

Accent Method (AM) of voice therapy: The AM targets holistically the improvement
of the respiratory, phonatory, articulatory, and gesticulatory aspects of verbal
communication in an integrated manner. The AM may be considered holistic also
from the vocal point of view as it collectively and simultaneously targets the various
parameters of voice such as pitch, loudness and timbre. The AM rests technically on
three major principles: (1) optimal abdomino-diaphragmatic breath support; (2)
rhythmic play of accentuated relaxed vowels with progressive carryover to connected
speech, and (3) dynamic rhythmic body and arm movements. The therapeutic
procedure consists of: (1) respiratory exercises; (2) phonatory exercises, and (3)
articulatory exercises, by which the beneficial new vocal habits are transferred to
connected speech. In the past, the accent method has been used successfully in
treating both organic and non-organic voice disorders.98-100

Of all of the voice therapy methods described above, the most researched voice therapy
intervention has been Vocal Function Exercises. To date, there are 23 peer-reviewed studies that
have demonstrated that VFEs are efficacious in enhancing vocal function in individuals with
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disordered voices, individuals over the age of 60 years diagnosed with presbylaryngeus and
professional voice users.18,19,22,35,36,69,87,88,91,101-114 In individuals with normal voices and elite voice
users such as singers, VFEs were effective in enhancing vocal function. Based on the disturbances
noted in voice production as a result of radiation-induced disruption in vocal fold vibratory
parameters, VFEs may prove efficacious in improving vocal function post-XRT.
In addition to a strong clinical evidence base, there are other factors that justify the use of
VFEs following XRT for laryngeal cancers. These factors have to do with the unique muscle
properties of intrinsic laryngeal muscles and the benefits of an exercise intensive program for
improving voice quality following radiation damage to the larynx. In the next few sections, the
reader will be informed on unique properties of laryngeal muscles, the effect of exercise on
skeletal muscles, motor control theory and the effect of radiation therapy on intrinsic laryngeal
muscles. These findings contribute to a strong case for using a physiologic approach to voice
therapy following XRT, which focuses on strength and balance training of the laryngeal
musculature, specifically through Vocal Function Exercises (VFEs).
Intrinsic Laryngeal Muscles (ILM), what sets them apart?
Since ILMs are skeletal muscles, they have been thought to resemble limb skeletal
muscles in terms of structure and function. However, unlike limb skeletal muscles, ILMs are
constantly active during respiration and are protective in function as they serve to protect the
airway. As a result it is important that these muscles remain more fatigue-resistant as compared to
limb skeletal muscles.115-117 Therefore with the unique demand placed on these muscles, it has
become apparent that they differ from limb skeletal muscles in certain key aspects. These
differences are discussed further in the present section.
Muscle fiber: Laryngeal muscle fibers are relatively smaller when compared to limb skeletal
muscles118 but are comparable to extraocular muscle (25-50 µm).119 The mean fiber diameter for
Thyroarytenoid (TA), Lateral cricoarytenoid (LCA), Posterior cricoarytenoid (PCA) and
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Cricothyroid (CT) is around 20-35 µm118 which is smaller compared to limb muscles, which
range from 35-75 µm.120
Contractile properties: The speed of contraction and sustainability of contraction of muscles are
determined primarily by the muscle’s myosin heavy chain (MyHC-I) isoform. In human skeletal
muscles MyHC-I yield slow contractions while IIa, IIx produce rapid contractions.121 In the rat
model, laryngeal muscles show Type I, IIA and IIB myosins.117 Studies in rats and non-human
primates suggest that the TA is nearly homogeneous in its myosin heavy chain expression, being
composed entirely of fast, type II myosin. 122,123 Unlike reports in the rat and non-human primate
model, human ILMs display a combination of fast and slow isoforms within a single muscle.
Muscles responsible for glottic closure and airway protection demonstrate faster MyHC isoforms
than abductors.115-117 Research on human laryngeal muscles has suggested that some laryngeal
fibers are capable of contractile speeds that far exceed those of limb muscles.124
Mitochondrial density: Mitochondrial volume density is the portion of cellular volume occupied
by the mitochondria (mitochondrial volume percent)125 or the percentage of the volume fiber
occupied by the mitochondria. TA, PCA and CT muscles show higher densities of mitochondria
when compared with limb skeletal muscles. 122,126 The constant activation of the muscle during
life sustaining functions such as respiration require these muscles to be far more fatigue-resistant
as compared to the typical demand of limb skeletal muscles.

Since we have now established that ILMs are different from limb skeletal muscles in
terms of size, role, and composition, the next section will describe the changes seen in laryngeal
tissues and musculature following radiation therapy.

Effect of radiation therapy on vocal fold tissue
The elements most at risk of radiation injury in the larynx are the epithelia- both
squamous and columnar- and the blood vessels. Cartilages of the larynx also appear to be an
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important site of delayed injury.127 The response of the larynx to radical doses of radiotherapy
varies from mild erythema to severe inflammation with edema and induration caused by
obliterative vasculitis and local ischemia.128 In a retrospective study of 348 patients receiving
radiotherapy as the primary treatment for laryngeal carcinoma, Mintz et al reported that chondritis
developed after curative-dose radiotherapy in 15% of their patients.9 There are very few studies
that have studied the effects of vocal fold muscle after radiation specifically. A study done by
Tedla et al.129 investigated the changes in muscle structure of irradiated intrinsic laryngeal
musculature. Comparisons were made between two groups of samples; those obtained from
patients who had the total laryngectomy as their primary treatment modality and those who had
salvage laryngectomy. Salvage laryngectomy is the term used for a total laryngectomy following
failure of primary radiation therapy. For the salvage laryngectomy group, the time post radiation
ranged from 7-15 months. The histological differences between the vocalis muscle, vocal process
of the arytenoid, cricoarytenoid joint and superior and recurrent laryngeal nerves were compared.
They found significant differences in the muscle structure as a result of radiation injury
characterized by decreased number of muscle fibers, widening of spaces between muscle fibers
and reorganization of muscle fibrils. These changes are indicative of increased atrophic changes
in the irradiated laryngeal muscle as compared to non-irradiated muscle. They also found a
change in the thickness of the perineurium of the recurrent laryngeal nerve and superior laryngeal
nerve. The thickness was lesser in the irradiated group as compared to the non-radiation group.
This could possibly influence the motor and sensory characteristics of the laryngeal vestibule.
Although this examination focuses on the role of the larynx in voice production, it is relevant to
note that this mechanism of injury may be a reason why swallowing problems characterized by
silent aspiration are prevalent in patients who have been irradiated. 43,130
A study by Johns et.al 31 demonstrated that human irradiated vocal folds demonstrated
increased collagen transcription, with increased deposition and disorganization of collagen in
both the thyroarytenoid muscle and the superficial lamina propria. An increase in fibronectin
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levels was noted in the superficial lamina propria. Laminin decreased in the thyroarytenoid
muscle. All of these findings would explain the decrease in vocal fold pliability following
completion of radiation therapy. Whole genome microarray analysis demonstrated increased
transcription of markers for fibrosis, oxidative stress, inflammation, glycosaminoglycan
production, and apoptosis. Post radiation changes therefore extend to the level of gene
transcription which can hinder treatment approaches that only target post- radiation structural
damage. Interestingly, the study also demonstrated an increase in collagen content as greater time
had passed since the completion of radiation therapy. This finding further highlights the late
effects of radiation toxicity.
Motor control theory and neuroplastic influences
From the studies that investigated voice quality after radiation therapy, it is apparent that
a number of changes in vocal quality are a result of faulty voice use. From the previous section it
is also apparent that a number of sensory and motor alterations take place as a result of radiation
therapy. Studies that performed laryngeal examinations after radiation therapy demonstrated that
this group of patients often exhibit compensatory behaviors such as laryngeal hyperfunction
which are not conducive to normal voice production.12,79 It is possible that as patients undergo
changes during and after XRT, they tend to develop adaptive and compensatory strategies as a
result of the various pathophysiological changes occurring during treatment. Theories of motor
control may help us understand this phenomenon better regarding not just physical changes but
also the various environmental changes that result from the experience of radiation therapy. The
field of motor control is directed at studying the nature of movement, and how movement is
controlled. Motor control is defined as the ability to regulate or direct mechanisms essential to
movement.131 Though application of motor control theories have been studied in greater detail in
the Physical Therapy and Occupational Therapy literature, researchers have more recently tried to
explain speech motor control based on these theories as well.132 Though these theories have not
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been applied to explain voice production, there are a number of overlapping concepts which
could better explain the compensation and adaptability of the vocal fold mechanism.
One such concept is the interaction between the feedback and feedforward system of
physiological motor control.133 This interaction between the two mechanisms could shed light on
the compensatory vocal behaviors developed as a result of radiation therapy. Feedforward
control involves all techniques for controlling a motor apparatus (the effector organs, for
example, muscle) without reference to one or more controlled variables (possibly muscle length
or joint angles) describing the current state of the motor system. In contrast, feedback control uses
some knowledge of the controlled variables to determine the outgoing motor commands. For
example, the controller could assess the difference between the sensed state of the motor
apparatus and a reference value for that variable. The controller could then seek to adjust the
difference using negative feedback.134 Considering the alterations to sensorimotor components
described in the previous section, the possibility of a shift in the feedforward and feedback
mechanism is inevitable. The shift that is possibly occurring in the feedforward and feedback
mechanism as a result of laryngeal injury secondary to radiation is probably why individuals
compensate through hyperfunction, which in turn produces a strained voice quality. This shift
which results in faulty compensatory voice production strategies also makes a case for why voice
therapy needs to be more task-specific and focus on changing movement based on striking a
balance between respiration, phonation and resonance. Another issue that further adds complexity
to ongoing structural changes is that sensory deprivation caused as a result of radiation damage to
the larynx is late onset. Studies investigating neuroplasticity have demonstrated that neuroplastic
changes are more striking early in life during the critical period of development.135 Therefore
retraining a highly specialized mechanism like the larynx , which is now mechanically injured,
genetically altered and which now suffers from late sensory deprivation, can prove challenging.
As involved as the peripheral motor and sensory systems are, the role of the cortex cannot be
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ignored. As is evident from studies, individuals continued to show compensatory and deviant
voice production years after radiation was completed. With ongoing alterations in sensory and
motor mechanisms consequently affecting the feedforward and feedback mechanisms, it is
possible that cortical representations are being altered as well. Areas for laryngeal control in the
cortex have been identified 136-138 and while the effects of radiation to the larynx on cortical
mapping have not been studied, it can be expected that the various sensory and motor changes
taking place would influence cortical reorganization as well. We shall describe the basis for our
theory of cortical reorganization in the next section.
Neuroplastic influences of voice problems on cortical representation: Cortical reorganization
following deafferentation and amputation has been studied extensively in the animal model. 139-144
Reorganization following amputation is similar in the pattern which it follows considering the
taking over of the now deprived field by neighboring areas. The formation of ‘new’
representations is also indicative of the fact that there are certain latent anatomical regions that
come into play when certain regions are completely deprived of sensory input, as seen in cases of
nerve resection or amputation. Deafferentation studies in adult macaque monkeys showed that it
was not just the receptive fields of the surrounding digits that took over the deprived area; but it
was also neighboring areas that represented the facial receptive field area that expanded over the
deafferented region.143 These findings were supported by further exploration of cortical
reorganization in adult primates.141 Similarly as changes in the perineurium of the recurrent
laryngeal nerve take place as a result of radiation therapy, it is possible that cortical
representations become weaker as a lack of sensory and motor input. Is this why patients in some
cases display severe dysphagia and voice issues over a long period of time after the completion of
radiation? As mentioned before, this has not been studied, and it is possible that laryngeal cortical
representations reorganize differently. But until investigated further, this can be considered as a
strong factor in recovery.
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In studies of cortical reorganization and recovery, one of the major influences in recovery
was activity-dependent neuroplasticity. The role of repetitive practice and increasing task
complexity has been linked to a better quality of neuroplastic change. Considering repetitive
nature of tasks, the role of exercise in neuroplastic changes has been the subject of investigation.
The next section focuses on the effects of exercise on neuromuscular changes and gene
expression.
Exercise and neuroplasticity in influencing gene expression: Plasticity is the interface between
physical and neural activity.145 Studies have repeatedly shown that, depending on intensity,
endurance exercise increases neurotrophins and thereby induces neuroplasticity.146-151 An increase
of Brain Derived Nerve Factor (BDNF) has been interpreted as an important factor raising adult
Central Nervous System (CNS) plasticity. In addition, aerobic exercise up-regulated expression
of insulin-like growth factor-I (IGF-1) and raised uptake of peripheral circulating IGF-I into the
brain.148,149,152 Studies have shown that IGF-I increases neurogenesis and also angiogenesis.146
Basal and exercise-induced angiogenesis are regulated in part by vascular endothelial growth
factor (VEGF). VEGF is produced by skeletal muscle cells during exercise and can be released
into the circulation, which also seems to be necessary for the effects of aerobic exercise on
neurogenesis.146 Considering findings on diminished vascular supply to tissues after radiation
therapy, this is a possible indicator that exercising laryngeal muscles may improve vascular
supply to the irradiated muscle. A study by Gomez-Pinnilla (2002)151 investigated the effect of
voluntary exercise on neuroplasticity. Voluntary exercise increased the expression of several
molecules associated with the action of BDNF on synaptic function and neurite outgrowth in the
lumbar region of the spinal cord and the soleus muscle. While we acknowledge that the study
focused on limb skeletal muscles, there were a number of interesting findings related to activitydependent plasticity. Their study demonstrated that voluntary physical activity can lead adult
sensory neurons to enhanced axonal regeneration after subsequent axotomy. 151 This again has
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been linked to the increase in neurotrophins following exercise. This study also emphasized the
effect that voluntary exercise has on synaptic plasticity subsequently improving neuromuscular
functions.151
Exercises and peripheral neuroplasticity: Exercise has been shown to be beneficial in not only
improving muscle strength in normal muscle, but also in aging and inflamed muscles.153 Using
high-intensity, low-repetitive, strength-type exercise, human skeletal muscle tissue exhibits
marked gains in strength that are due both to neuronal adaptations and to an increase in muscle
cross-sectional area. 154 A study by Luthi et al studied the effects of resistance training on muscle
structure in human subjects.154 They found an increase in muscle cross sectional area and muscle
size. Structural and functional properties of skeletal muscle generally correlate to the level of
demand placed on individual muscles.154 As demand increases, skeletal muscle can adapt via an
increase in myofiber size and an alteration in the composition of the metabolic and contractile
proteins expressed.95 Training programs that have employed relatively pure shortening,
lengthening, or isometric loading have demonstrated that each of these three modes of loading
can stimulate muscle adaptations, including hypertrophy and strength gains.94,154 It is well
established that a prolonged program of resistance training brings about fiber type conversions
within the trained muscle.94,154 These findings are also influenced by repetitive exercise patterns.
Most changes were observed after the first 4 weeks of exercise. One of the methods of
documenting if these changes are more permanent would be to document changes in gene
expression as a result of exercise. These changes would be indicative of a more long-lasting
change in muscle structure. Would resistance exercises during the radiation period slow down or
nullify delayed injury? If yes, voice therapy could have important implications on not just voice
but swallowing rehabilitation as well. A study by Booth and Neufer (2005)155-157 describes the
mechanism of gene expression following exercise. If work demand on a muscle increases even
for relatively short periods, the muscle adaptively remodels its protein composition to allow
energy to be used more efficiently when the muscle contracts. For skeletal muscles to exhibit
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plasticity, specific genes in the muscle sense the change in muscle usage and respond by altering
the quantities of proteins they produce. Neufer155 measured gene changes by measuring mRNA
concentration, or how quickly a specific gene was transcribed. He investigated whether exercise
activated a specific target gene and whether this took place within a specific time period. Three
categories of genes were expressed as a result of exercise, mainly endurance training, based on
the duration of their activities. These included 1) stress response genes (mainly consisting of heat
shock proteins) which were activated during the later phases of endurance training, 2) metabolic
priority genes: proteins which are required as a consequence of particular metabolic stress, for
example when blood glucose or blood oxygenation levels drop, and 3) mitochondrial enzyme:
which is directly responsible for the energy production in a cell.
Though these changes were documented in limb skeletal studies, the concept can be
applied to endurance training with intrinsic laryngeal muscles. Changes in muscle composition
based on the effect of fictive exercise in normal rat intrinsic laryngeal muscle have been
established.158 It would be of interest to see the changes in gene expression and muscle
composition following radiation therapy.
The effect of exercise on vocal fold muscles
From the previous sections it is clear that while ILMs are skeletal muscles, they are
highly specialized as compared to limb skeletal muscles. As is apparent from previous studies
there is ample evidence to conclude that endurance and resistance exercises improve muscle
strength in the limb skeletal muscle. However, in the previous section we also highlighted the
differences between limb skeletal and intrinsic laryngeal muscles. It is apparent that intrinsic
laryngeal muscles resemble extraocular muscles and are more fatigue-resistant than fast
contracting skeletal muscle fibers. However, basic substrates that drive muscle strength such as
mitochondrial content, oxidative metabolic capacity and quantity of neuromuscular junctions
remain common between both limb skeletal and intrinsic laryngeal musculature. The effects of
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chronic electrical stimulation on the rat TA muscle were investigated by McMullen et al (2011).
158

The thyroarytenoid muscle was stimulated via nerve cuffs on the recurrent laryngeal nerve for

a period of one week for one group and two weeks in the other group. Differences in muscle
structure were compared at one-week intervals and two-week intervals. The authors found a
decrease in mean thyroarytenoid fiber area, evidence of higher mitochondrial content in the
muscle after chronic stimulation, and increase in the number of neuromuscular junctions in
muscles that had been stimulated. These findings are similar to those changes seen in other
skeletal muscles after endurance training. 159,160 The stimulated thyroarytenoid muscles displayed
increased oxidative metabolic capacity which is a sign of adaptive progression in fast-twitch limb
skeletal muscle undergoing endurance training. 161 The increase in neuromuscular junctions in
stimulated group was also a significant finding. Previous studies have reported an increase in
neuromuscular junctions (NMJ) as a sign of activity dependent plasticity.162 Increased
neuromuscular activity can influence NMJ structure, with NMJ remodeling being a common
finding after endurance and resistance exercise. An increase in NMJ quantity or density would
lead to an increase of the area in contact with the muscle fiber, which would result in more
release sites and greater levels of transmitter release. 163 The only finding that did not match
findings from other studies was a decrease in fiber size instead of an increase. The authors
speculate the reduction in fiber size was possibly due to lack of load applied to the muscle. 164
From the previous sections it is clear that exercise seems to be important in facilitating
activity-dependent plasticity. More importantly, changes after exercise appear to be more longlasting since they influence gene expression.
Summary
It is clear from outcomes studies after radiation therapy that XRT adversely affects voice
production.12,30,81,165 There are a number of studies which have documented changes in vocal fold
structure, objective voice data and also microscopic changes that influence laryngeal
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tissues.12,30,81,165 The changes occurring at tissue level appear to be inflammatory, causing muscle
weakness and stiffness.62,129 In addition, changes to the nerve and blood supply have also been
documented.31,129 More concerning, ongoing changes are noted at the level of gene transcription
even after completion of radiation therapy.31 The paucity of research on the treatment of these
long-standing voice problems is concerning as well. The present review attempted to decide
whether there is a rehabilitation method that would best treat voice disorders in this population.
From reviewing rehabilitation research across other disciplines like physical and occupational
therapy, exercise emerges as a common theme for neuromuscular rehabilitation. Though the
effect of exercise has been studied in limb skeletal muscle more extensively, the basic mechanism
of inflammation and exercise-based changes are similar to those seen in vocal folds after
exposure to radiation. Considering the changes seen in the muscular and vascular damage in
intrinsic laryngeal muscles as a part of radiation injury, exercising seems to be the choice of
treatment to regain structural integrity. Studies state that exercise not only reduces inflammation
but also promotes angiogenesis.146,150,152,161 These changes seem to occur in the presence of
resistance and endurance training.146,150,152,161 When exercise was simulated in the rat intrinsic
laryngeal muscles, changes seen were similar to those reported in limb skeletal muscles after
endurance exercise, which is indicative of common strengthening patterns seen in ILMs after
exercise.163 These changes were reflected in an increase in mitochondrial content as well as an
increase in neuromuscular junctions.163 The increase in neuromuscular junctions is an indicator of
activity-dependent plasticity as a result of exercise. Though these changes have never been
studied in the larynx areas in the cortex, based on limb exercise research and amputation and
deafferentation studies, cortical changes secondary to laryngeal muscle exercise is a feasible
possibility. This could also be indicative of permanent changes occurring as a result of gene
expression due to exercise. 156,157,163
While evidence on exercise and neuroplastic changes is still speculative and needs to be
investigated further, the need for more concrete, exercise-based voice rehabilitation is apparent
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from voice therapy outcomes studies. The Vocal Function Exercise program is a prescriptive
exercise program and is presently the most researched therapy program compared to other voice
therapy interventions. However, we fully acknowledge that the choice of therapy methods across
these studies is subjective, and we need more extensive and well-planned studies for voice
therapy outcomes. The decision for a therapy plan for the irradiated laryngeal cancer population
can only be made once the effects of various voice therapy methods are studied in greater detail.
Until now, there have four studies that reported the positive effects of voice therapy in this
population, but the intervention methods have not been specified.13-16
The gap in research between disorder and treatment in this population is glaring. Based
on the findings of this review, it appears as though a starting point for voice rehabilitation in this
population is exercise that aims to strengthen the sub-systems of voice production. The VFE
program is the only program presently that aims to strengthen and rebalance the laryngeal
musculature through a series of resistance and endurance exercises. The first step to voice
rehabilitation would logically be to set a strong neuromuscular foundation and in addition retrain
the irradiated laryngeal system by implementing VFEs to gain strength and balance of the
laryngeal mechanism.
The next chapter includes a detailed description of the first stage of the investigation
targeted towards the completion of this dissertation study. This stage focused on characterizing
the head and neck cancer population at a single center, the University of Kentucky Medical
Center. Rehabilitation following laryngeal cancers is especially relevant to the population in
Kentucky largely because of the high incidence rates of laryngeal cancers, and HNCs in general
in the state. This study stage helped identify individuals who were irradiated for laryngeal cancers
for later stages of the dissertation.
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CHAPTER 3: STUDY I
Study title: Addressing the head and neck cancer burden in Appalachian Kentucky: A single
center experience
Chapter 3 describes stage I of the dissertation study in detail. This stage of the study
helped in identifying patients irradiated for laryngeal cancers at the University of Kentucky.
However, in addition to laryngeal cancers, an increased incidence of head and neck cancers
(HNC) has been reported in the state of Kentucky since 2007. In fact, at 13.5% Kentucky has the
highest incidence of head and neck cancers in the United States. 24,37 As described in previous
sections, laryngeal cancers are a sub-group of head and neck cancers (HNCs). Therefore, instead
of limiting our investigation to laryngeal cancers only, we characterized the distribution trends of
all HNCs seen at the University of Kentucky to highlight the HNC burden in Appalachian
Kentucky. The present section includes the background, specific aims, methodology, results and
discussion directly related to study 1.
Background
Appalachian regions across the United States include 420 counties in 13 states 166 and are
known to be regions associated with significant health disparities. 166,167 Health disparities
between Appalachian and non- Appalachian counties have chiefly been attributed to the
geographic isolation of most Appalachian counties, low socioeconomic status, low levels of
education and literacy, and limited access to healthcare.166 These health disparities result in higher
rates of heart disease, stroke,168 chronic conditions and cancer in Appalachian vs. nonAppalachian regions. 166,169,170 The growing incidence of cancer in Appalachia has been of great
concern with cancer incidence and mortality rates being much higher as compared to nonAppalachian regions.170 Increased incidence and mortality of cancer holds true for the
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Appalachian counties within the state of Kentucky as well,24 in fact, to an even much graver
degree .167
Studies have shown that the 54 Appalachian counties of Kentucky have socioeconomic
status factors which are the poorest among all Appalachian regions of the United States .171
Limited finances and limited access to medical facilities has resulted in the medical needs of this
population remaining largely underserved .166,167,172,173 With limited access to healthcare, it is not
surprising that Appalachian regions of Kentucky show a higher incidence of lung, colorectal,
cervical and head and neck cancers as compared to non- Appalachian regions.169 Associations
such as Appalachia Community Cancer Network (ACCN) and Appalachian Regional Health
(ARH) are attempting to address this growing incidence of cancers in Appalachian Kentucky
through education and early detection programs.174 The Appalachia Community Cancer Network
(ACCN) comprises a multidisciplinary team of collaborators from academic institutions and
communities in Kentucky, West Virginia, Ohio, Pennsylvania, New York, Maryland, and
Virginia. The ACCN, located at the University of Kentucky's Markey Cancer Center, addresses
cancer health disparities in the Appalachian areas within these seven states, which are home to
some of the most medically underserved and economically disadvantaged people in the United
States.174
While the ACCN has made significant efforts in Eastern Kentucky to address the cancer
burden related to colorectal, lung, breast and cervical cancers ;167,175,176 the head and neck cancers
have not been addressed. The incidence rates for head and neck cancer statistics for Kentucky in
general have not been favorable.177 According to recent data reported by the Kentucky Cancer
Registry (2007-2011), at 13.5 percent, Kentucky has one of the highest reported incidence of
head and neck cancers (HNC) in the United States. 24,177 This is a matter of great concern since
Kentucky is one of the few states where incidence rates of HNC have increased in the past few
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years. 25 The rising incidence in HNC can be attributed to a high prevalence of smoking in the
state at 28%, which is also the highest smoking prevalence rate in the country. 29
When detected early, HNC are highly treatable and have significantly better five-year
survival rates and low rates of treatment related morbidity.178,179 Improved treatment morbidity is
due to the single modality treatment that is required to combat early cancers.175 Treatment for
advanced stages of HNC results in significant morbidity including severe detrimental effects on
speech and swallowing. 39 Multiple interventions including surgery, radiation therapy,
chemotherapy, other surgeries and subsequent rehabilitation as a result of these treatments
contribute to severe detrimental effects on quality of life and consequently increases treatment
costs.175 These costs are related to the required multimodality treatments and multiple
professionals involved in direct patient care. For patients who are financially compromised in
regions such as Appalachian Kentucky, treatment costs only add to the disease burden.
When assessed in totality, the multiple referenced hurdles to medical care (high
prevalence of smoking, geographical isolation, low socioeconomic status, low literacy, lack of
awareness of health risks related to lifestyle) contribute to challenges in addressing and managing
the HNC burden in Appalachian Kentucky. Therefore an effort needs to be made to identify and
address the medical needs for HNCs in Kentucky, especially Appalachian Kentucky in order to
plan educational, screening and prevention programs. To effectively plan such programs, it is
important to first characterize the HNC population in the targeted region. The present study
characterizes the HNC population at the University of Kentucky (UK) otolaryngology clinic and
HNC clinic at the Markey Cancer Center. The University of Kentucky otolaryngology clinic and
HNC clinic are considered tertiary care centers for cancer management. The HNC clinic is
located in the Markey Cancer Center (MCC). The Markey Cancer Center is also Kentucky’s only
National Cancer Institute (NCI) designated center. The Markey Cancer Center at the University
of Kentucky is located in central Kentucky and serves a large number of patients around
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Kentucky (both central and eastern) as well as some surrounding states .176 We believe that the
sample collected through the present study is a close representation of trends seen across the state.
The objective of the present study was to characterize the head and neck cancer
population at the University of Kentucky over a 3-year period. Factors under study included
trends in basic demographics, site of lesion, staging information, treatment types and tobacco use.
Through this study we aimed to highlight the differences in trends between the Appalachian and
non-Appalachian regions of Kentucky. Characterizing the HNC cancer population and
highlighting differing trends between the two regions within Kentucky helps healthcare
professionals identify high risk regions. Once identified, these high risk regions can be targeted
for outreach, screening, education and health programs that promote increased awareness, early
identification, and prevention of head and neck cancers.
Specific aims
Specific aim1: To characterize the distribution of head and neck cancers in the treatment seeking
population at a University of Kentucky Markey Cancer Center in terms of site, stage, treatment
trends, tobacco use and basic demographics in patients who sought treatment from January 2008
to December 2010.
Specific aim 2: To compare the distribution of head and neck cancers across Appalachian and
non-Appalachian counties. Given the higher rate of tobacco use in Appalachian in comparison to
non-Appalachian counties,169 we hypothesize that a larger number of patients identified at UK
will belong to Appalachian counties.
Specific aim 3: To compare stage of cancer at the time of detection across Appalachian and nonAppalachian counties. Considering the limited access to medical facilities faced by the
Appalachian population ,167,171,180 we hypothesize that the Appalachian population will have more
advanced stage cancers at the time of their first visit.
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Methods
Following approval from the Institutional Review Board (IRB) at the University of
Kentucky, data for the present study were obtained from the Kentucky Cancer Registry (KCR).
KCR is part of the Surveillance, Epidemiology, and End Results (SEER) program, which is
considered to be among the most accurate and complete population-based cancer registry
programs in the world.179 Using the SEER site ICD-O-3 definitions, 181 cancers included in the
final analysis included cancers of the lip (C00.0-C00.9), tongue (C01.9-C02.9), salivary glands
(C07.9-C08.9) , floor of mouth (C04.0-C04.9), gum and other mouth (C03.0-C03.9, C05.0-C05.9,
C06.0-C06.9), nasopharynx (C11.0-C11.9), tonsil (C090-C099), oropharynx (C100-C109), other
oral cavity and pharynx (C14.0, C14.2-C14.8), larynx (C32.0-C32.9) and esophagus (C15.0C15.9). Since this was a single site study, only data from patients seen at UK were included. Data
were collected for patients diagnosed from January 1, 2008 to December 31, 2010. The following
data were included in the final analysis; age at time of diagnosis, sex, county at diagnosis, site of
lesion, AJCC stage at the time of diagnosis (American Joint Committee on Cancer -Sixth
edition),182 type of treatment administered and tobacco use. Since the entire treatment seeking
population in the three year period was included, there were no exclusions made based on age or
number of primaries. One of the main objectives of this study was to investigate the differences in
the above mentioned data between non-Appalachian and Appalachian counties for all included
counties. Appalachian and non- Appalachian counties were determined according to the
Appalachian Regional Commission classification.
Statistical analysis
Statistical analyses were completed using SPSS Ver.21. Main analyses included
frequencies of the factors under study (i.e. age, sex, county, site of lesion, county- wise
distribution, stage at the time of diagnosis, type of treatment administered and tobacco use).
Using a Fisher’s exact test, comparisons were made between non- Appalachian and Appalachian
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counties for the following factors: stage at the time of diagnosis, type of treatment administered
and tobacco use. All tests are two sided with a 0.05 significance level.
Results
Basic demographics: A total of 476 patients were diagnosed with head and neck cancers at the
University of Kentucky between January 1, 2008 and December 31, 2010. HNC were more
prevalent in males as compared to females (3:1). The mean age of diagnosis was 58.61 years
(SD=10.9) for males and 59.1 years (SD=13.1) for females. The most common type of HNC was
squamous cell carcinoma which is similar to trends nationally and worldwide. The most common
site of lesion was laryngeal cancers which made up 28% of the total sample (Table 3.1). In terms
of tobacco use, 72% of the total sample was tobacco users (Table 3.2). Tobacco use included
cigarette smoking and smokeless tobacco. When comparing treatments, a majority of patients
(27%) received primary chemoradiation therapy (Table 3.3).
Appalachian versus non-Appalachian comparisons: Comparisons were made with respect to
total number of people diagnosed, stage at the time of diagnosis, treatment type and tobacco use
between the Appalachian and non-Appalachian population. A total of 45 Appalachian counties
and 22 non- Appalachian counties were included in the final analyses. Appalachian and nonAppalachian counties were determined based on the Appalachian Regional Commission (ARC)
classification.183
The number of people diagnosed between January 1st 2008 and December 31st 2010 was
higher in Appalachian counties (n=278) as compared to non- Appalachian counties (n=198).
There were a higher number of patients diagnosed with advanced stage disease (Stage III-IV) in
Appalachian counties (n=160) as compared to non- Appalachian counties (n=135). However,
when compared to the total population under study, the percentage of patients diagnosed with
advanced disease was higher in non-Appalachian regions as compared to Appalachian regions. A
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Fisher’s exact test was performed to analyze if there was a difference in the number of people
diagnosed with late stage HNC in Appalachia as compared to non- Appalachian regions. Results
showed that there was a significant difference between the Appalachian and non- Appalachian
population (Table 3.5). The number of people who received multi-modality treatments was larger
in Appalachian Kentucky as compared to non- Appalachian Kentucky; however these numbers
were not statistically significant (Table 3.6). Tobacco use was comparable in Appalachian and
non- Appalachian counties (72%) (Table 3.2).
Discussion
The present study was a single center hospital based study with the objective of
characterizing the head and neck cancer population at the University of Kentucky over a 3-year
period. Data from the present study serves as preliminary data to investigate differences seen in
Appalachian and non- Appalachian Kentucky, at a single tertiary care center in urban Kentucky.
We propose to perform a larger study which includes state-wide data to further highlight the HNC
burden in Appalachian Kentucky.
According to the recent population census, non- Appalachian Kentucky is roughly three
times more populated then Appalachian Kentucky 184 Despite this difference in population, the
present study showed a higher number of patients with HNC in Appalachian Kentucky compared
to non- Appalachian Kentucky. An important risk factor for HNC, smoking rates were
comparable between Appalachian and non- Appalachian counties. However, an important factor
that was not assessed was alcohol consumption in combination with smoking. Alcohol
consumption in addition to smoking increases the risk for HNC by tenfold .27,28 This is a
limitation which needs to be addressed for future studies. In terms of total numbers, Appalachian
Kentucky also showed a higher number of patients diagnosed with advanced stage disease as
compared to non- Appalachian Kentucky. However, when compared to the total population under
study, for Appalachian and non- Appalachian regions included in the present study, non39

Appalachian regions showed a higher percentage of patients diagnosed with advanced stage
disease. This is possibly because majority of patients diagnosed with HNC belong to Fayette
county; an urban county, which is also where UK is located. This is a limitation since data from
the entire state of Kentucky were not included. Despite this limitation, higher numbers of patients
from Appalachia were seen at an urban tertiary care center in Kentucky (University of Kentucky)
as compared to patients from non- Appalachian regions. These numbers continue to highlight the
elevated HNC burden in Appalachia. The elevated number of patients diagnosed with HNC and
the advanced disease stage add to the cost burden of the disease in an already financially
compromised population.
The unique health issues faced by the Appalachian population in Kentucky have long
been a topic of discussion. Appalachian Kentucky’s ‘All Cancer Rate’ is 17% higher than that of
the national rate. 185 The National Cancer Institute (NCI) has recognized Appalachians as a
population with severe cancer disparities.180 Some of the issues that have been identified to
contribute to these health disparities include lower levels of literacy and low socioeconomic
status. 186 A study by Elnicki et al. listed lack of knowledge about prevention (51%) and cost
(36%) as the top two patient perceived barriers to seeking healthcare in Appalachia .172 The
geographic isolation of Appalachia further compounds the issue of ease of access to standard
healthcare. The problem of access to health care services is magnified in rural areas that are
remote and exist well outside urban boundaries where transportation is limited .172,186
To complicate matters further, problems related to health disparities in Appalachia are
not limited to socioeconomic, geographic or environmental factors. Unfortunately problems
related to health disparities in Appalachia are deeply rooted in the Appalachian culture and the
attitudes towards seeking healthcare in general. Perceptions of the Appalachian population
towards cancer have been the topic of various studies as well. 166,171,186 People in Appalachia
believe that contracting cancer is inevitable, thus ignoring the role of prevention. 187 Most
Appalachians have a fear of doctors and do not seek medical help when require. 187 Since most
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Appalachians are economically challenged, missing work to seek medical help is not an option.
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For the past few years, several screening programs have been implemented for colorectal,
cervical, breast, ovarian and prostate cancers. One example of a successful screening program for
Kentucky is the colorectal cancer screening program. Ten years ago, Kentucky had the second
lowest screening rate in the country and had one of the highest incidences of CRC in the country.
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However, with joined efforts from Colon Cancer Prevention Project, American Cancer

Society, the Kentucky Department for Public Health, the Kentucky Cancer Program, the
Kentucky Cancer Registry and a few other organizations within the Kentucky cancer consortium,
the incidence rate for colorectal cancer has reduced by 25 percent and the death rate has reduced
by 28 percent .188 From barriers listed above which include economic, environmental,
geographical barriers and a negative attitude towards seeking healthcare; it is apparent that
outreach is the need of the hour. Consequently, outreach programs need to focus on education and
prevention, early identification and screening. Screening programs also must be affordable. HNC
screening, protocols and instrumentation are relatively affordable especially when compared to
those required for colorectal, prostate, breast, cervical or ovarian cancers .179 Ideally, screening,
educational and prevention programs can be propagated by healthcare professionals known to the
community, such as primary healthcare providers (PCP). To this end, PCPs need to be educated
and trained on HNC screening procedures, knowledge on prevention of HNC and the importance
of early detection and intervention. Subsequently, educational programs for HNC screening,
prevention and early detection and intervention can be expanded to community health workers
such as nurses, dental hygienists and community aid workers. The idea is to provide easy access
to patients closer to their homes where they do not need to arrange finances for transportation.
Reaching out to patients through means within the community would certainly help in
overcoming barriers of geographical isolation. A low cost screening program also reduces the
financial burden of a physician’s visit. We recognize that issues related to increasing HNC
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incidence in Appalachian Kentucky extend beyond the low socioeconomic status of Appalachian
Kentucky and the lack of access to healthcare. A general change in attitude towards seeking
healthcare in the Appalachian population is just as vital. Implementation of screening, educational
and prevention programs would only be the first of many steps towards tackling a serious
problem faced by the people of Appalachian Kentucky, one that should no longer be ignored.
The next chapter will provide the reader with a detailed description of stage 2 of the
present dissertation study. Individuals irradiated for laryngeal cancers identified from stage 1
were recruited for stage 2 of the study. Stage 2 involved characterizing vocal function in
individuals irradiated for laryngeal cancers.
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CHAPTER 4: STUDY 2
Study title: A study of vocal function using a multi-dimensional assessment battery in adults
irradiated for laryngeal cancer
Chapter 4 describes Stage II of the dissertation study in detail. As described in previous
chapters, vocal function is best assessed using a multidimensional assessment battery which
encompasses physiological and psychosocial factors of voice production. The objective of the
present study was to characterize vocal function in adults irradiated for laryngeal cancers using
the five domains of voice assessment. The present irradiated study population was also matched
in age, sex and pack years of smoking to a control group of adults without history of irradiation
for head and neck cancers. The next few sections inform the reader on background, study
methodology and results of the present study. This chapter also includes a detailed discussion of
the study findings.
Background
Primary radiation therapy (XRT), with or without chemotherapy, has proven to be an
effective curative modality in the treatment of both early and advanced laryngeal cancers. Early
laryngeal cancers are often treated with radiation therapy alone,1,189 while advanced laryngeal
cancers are treated with a combination of radiation therapy and chemotherapy.32 Since the 1990s,
an increasing number of patients are being treated with primary radiation therapy, with or without
chemotherapy.31 The intent of treating laryngeal cancers in this manner is to preserve laryngeal
structure and function while eliminating disease.31 However, a number of post-treatment studies
have demonstrated poor voice and swallowing outcomes as a result of radiation toxicity. Voice
and swallowing dysfunction following radiation are indicators that preservation of laryngeal
structure is not necessarily translating into preservation of laryngeal function for these patients.

43

These voice and swallowing changes are known to persist over long periods of time and in some
cases are permanent.
A number of studies have documented the effects of radiation on vocal function.1,9,30,32
However, these studies have often used limited outcome measures which do not capture the
multidimensional nature of vocal function. Normal voice production is dependent upon the
physiological and psychosocial aspects of voice use. Physiologically, normal voice production
requires an interaction among the three subsystems of voice production: respiration, phonation
and resonance. Psychosocial factors reflect the individual’s voice use with respect to activities of
daily living. To incorporate these physiological and psychosocial domains to provide a holistic
description of an individual’s vocal function, voice production should ideally be assessed using a
multidimensional assessment battery.33 Hirano190 stated, “Voice is multidimensional in nature, so
we need a set of tests to evaluate function in its entirety.” This sentiment was reiterated by Titze
et.al.,who stated, “Diagnostic hypotheses should not be made on basis of one test or measure
because one cannot look at an isolated phenomenon without running the risk of misinterpreting
the results”. 191,192 Multidimensional assessment of voice helps overcome the limitations of any
one assessment type. 191
Select assessment parameters within these domains have been recommended by
researchers in the field of voice disorders based on their reliability and validity measures. The
measures recommended through research were used in the present study. The five domains of
voice assessment include stroboscopic (laryngeal visualization), acoustic, aerodynamic, patient
self-report and auditory-perceptual parameters.33 Study parameters within the five domains of
voice assessment are presented in Table 4.1. The next section informs the reader on clinical
findings in select parameters of voice assessment following XRT. The findings are divided
according to the parameters within each of the five domains of voice assessment.
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Auditory-Perceptual findings: Auditory perceptual findings from previous studies report varied
vocal symptoms. These studies used an informal scale for perceptual assessment and not a
standardized scale such as the GRBAS or CAPE-V.51,53 Perceptually patients often present with
hoarseness, decreased volume, increased strain and persistent voice changes.8,13,81
Voice related quality of life: A recent study by Karlsson, et al. (2016) 17 that investigated voicerelated quality of life measures in patients with early and advanced laryngeal cancers revealed no
significant differences between pre-radiation and post-radiation scores one year after completion
of treatment. These results indicate that the deterioration in voice quality perceived by the patient
as a result of laryngeal cancer did not improve after completion of treatment to eliminate laryngeal
cancer.17 A study that investigated voice problems as a result of radiation for early glottic cancers
demonstrated that 87.8% of the patient sample reported their voice as being abnormal, ranging
from slight to moderate dysfunction.82
Acoustic measures: The majority of studies showed that radiation therapy had a negative impact
on voice quality, as revealed by increased perturbation and noise measures. Voice quality was
gradually found to improve over 3-6 months post-radiotherapy. However, none of the posttreatment perturbation values fell within the normal range. 78-80
Aerodynamic measures: McGuirt et al. (1994)12 revealed mean laryngeal airway resistance (LAR)
values 4.5 times greater than normal values (mean=177cmH2O/L/s) in patients who had been
irradiated for T1a glottic cancer. These LAR values are comparable to those in a study by Aref
(1997)30 who found that none of 12 patients attained normal aerodynamic measures. Increased
airflow rates in patients who had undergone radiotherapy (n=6) were also observed in a study by
Tamura (2003)79 in which mean airflow rates of 165 cc/s were measured. Increased aerodynamic
resistance values reflect the signs of supraglottic hyperfunction seen stroboscopically and are also
indicative of issues with reduced glottal valving.
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Laryngeal imaging (Stroboscopic findings): In a detailed study performed by Lehman et al
(1988),77 significant abnormalities were seen on stroboscopic analysis in patients irradiated for
stage I glottic cancers. Around 60% of patients showed irregular vocal fold closure, 65%
increased supraglottic activity, 85% irregular vibratory margins, 80% shorter closure phase and
85% irregular phase symmetry. The stroboscopic finding consistent across the group was
decreased vibratory amplitude not only on the treated vocal fold but also on the non-diseased
fold. These findings were consistent with those in a study by McGuirt et al. (1994)12 that reported
decreased mucosal wave on both the treated and non-diseased fold. In addition, subjects showed
signs of muscle tension dysphonia, ventricular phonation, and partial antero-posterior
compression.
From the study findings described in the previous section, it is clear that multiple
domains of vocal function are affected as a result of radiation toxicity to the laryngeal
mechanism. To this end, in the present study we characterized vocal function after radiation
therapy for laryngeal cancers as assessed holistically by all five domains of voice assessment.
The next section describes aims specific to stage II of the dissertation.
Specific aims
Specific aim 1: To characterize vocal function in subjects who have been treated with radiation
therapy for laryngeal cancers as determined by stroboscopic imaging; high-speed digital laryngeal
imaging; acoustic, aerodynamic, and perceptual analyses; and patient self-report measures.
Previous studies have reported post-radiation therapy deterioration of select parameters within
the five domains of voice assessment. None have included all five domains in the same study. We
hypothesize that the present study results will follow similar trends.1,12,30,77,193
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Specific aim 2: To compare vocal function in individuals who have been treated with radiation
therapy with age, sex and pack-years matched controls as determined by stroboscopic imaging,
high-speed laryngeal imaging, acoustic, aerodynamic, perceptual and patient self-report
measures. Previous studies have reported deterioration in vocal function after radiation
therapy.1,12,30,77,193 However, additional factors such as tobacco smoking and age-related changes
have been known to affect vocal function adversely as well.194,195 To account for these factors, we
matched subjects in the control group based on age, sex and tobacco use. We hypothesize that the
present study will show clinically worse values of vocal function in the irradiated group as
compared to the control group.
Methods
Participants for Stage II were recruited from the multidisciplinary head and neck cancer
clinic at the Markey Cancer Center (University of Kentucky) following approval from the
Institutional Review Board (IRB) at the University of Kentucky (UK). A sample size of 20, with
10 participants in each group was required to achieve 80% power to detect a difference of 12
points in VHI between healthy and irradiated individuals at a significance level of 0.05.16,196 Stage
II was designed as a cohort study.
Participants
After completion of informed consent, 18 participants were included in the study based
on inclusion and exclusion criteria. Participants in the radiation therapy group met the following
inclusion criteria: adults over 18 years of age, previously irradiated for laryngeal cancer (with or
without chemotherapy), hearing levels appropriate to follow directions, and deemed cancer-free
at the time of study recruitment. Participants had to have completed XRT at least 6 months prior
to study participation. Presence of vocal fold paralysis or surface vocal fold pathology at the time
of study recruitment constituted exclusion from the study. Participants in the control group met
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the following inclusion criteria: adults over 18 years of age, former/current/non-smokers, hearing
levels appropriate to follow directions and no history of head and neck cancer. Presence of
surface vocal fold pathology, vocal fold paralysis or neurological disorder constituted exclusion
from the study. Participants in the control group were recruited based on age, sex and pack years
of smoking parameters as compared to the radiation group.
Assessment battery
Participants in both groups underwent the same multidimensional vocal assessment
battery. The battery included assessment protocols belonging to the five domains of voice
assessment. A checklist for the assessment battery is available in Appendix I. The five common
domains of voice assessment are: auditory-perceptual measures, patient self assessment, acoustic
analyses, aerodynamic analyses, and laryngeal imaging or visual perceptual assessments.
Outcome measures and their normative values are available in Table 4.1. Outcome measures are
listed below with reference to each domain of voice assessment.
1) Auditory- Perceptual assessment: Consensus Auditory Perceptual Evaluation of Voice
(CAPE-V- Appendix II) was utilized. Blinding: Audio samples of patient’s voices reading the
rainbow passage (Appendix III) were presented to a licensed and certified speech-language
pathologist with over 40 years of clinical experience in the field of voice disorders. The
assessor was blinded to group assignments.
2) Patient self-assessment: Voice Handicap Index (Appendix IV) was utilized. Total scores and
domain specific scores (Physical, Functional, Emotional) were included for final analysis.
3) Acoustic analyses: The Multidimensional Voice Profile (MDVP) and Analysis of Dysphonia
in Speech and Voice (ADSV) were utilized. Specific measures included jitter, shimmer, noise
to harmonics ratio (NHR), maximum phonation time (MPT) and pitch range for MDVP; and
Cepstral Spectral Index of Dysphonia (CSID) for ADSV stimuli.197 CSID included sustained
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vowel and sentence stimuli. Sentences included easy onset, voiceless plosive, all voiced and
hard glottal attacks.
4) Laryngeal imaging/visual perceptual assessment: Measures included were laryngeal
stroboscopy and high speed laryngeal imaging. Stroboscopic and high speed features were
rated on a scale (Appendix V). Stroboscopic and high speed parameters include glottic closure,
mucosal wave, amplitude of vibration and phase symmetry. Ratings were performed by a
licensed and certified speech-language pathologist with over 40 years of clinical experience in
the field of voice disorders. The speech-language pathologist was blinded to group
assignments.
Instrumentation
1) Laryngeal stroboscopy: Laryngeal stroboscopy was performed using the Kay Elemetrics
Rhino-Laryngeal Stroboscope – (Model RLS 9100 B, Halogen lamp: 150 watts, Xenon lamp: 120
watts, frequency range: 60 Hz – 1000 Hz, laryngeal microphone), a Kay Elemetrics 70 degree 22
rigid scope (Model 9106, total length: 252 mm), Kay distal endoscope, and a C-mount camera
(Panasonic 3CCHD).
2) High speed digital imaging: For the HSDI recordings, a KayPentax high-speed system model
9710 was used. Images were recorded at 4000 frames/s for a maximum duration of 4 seconds
with a spatial resolution of 5123256 pixels. A 300W Xenon light source was used
3) Acoustic analysis: For acoustic assessment, the Computerized Speech Lab Model 4500 by
KayPentax was used with a hand-held microphone (mouth-to-microphone distance = 3 inches)
[System Requirements: Analog Inputs: 4 channels: two XLR and two phono-type, 5mV to 10.5V
peak-to-peak, adjustable gain range >38dB, 24-bit A/D, Sampling Rates: 8,000-200,000Hz,
THD+N: <-90dB F.S. Frequency Response (AC coupled): 20-22kHz +.05dB at 44.1kHz. Digital
Interface: AES/EBU or S/P DIF format, transformer-coupled. Software Interface: ASIO and
MME. Computer Interface: PCI (version 2.2-compliant), PCI card; 5.0" H x 7.4" W x 0.75" D
(half-sized PCI card). Analog Output: 4 channels, line and speaker, headphone output, channels 1
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& 2 provide line & speaker outputs. Physical: 4" W x 8.25" H x 12.5" D, 4 lbs. 12 oz., 45 watts,
speaker, and microphone (Shure SM-48 or equivalent, XLR-type)].
4) Aerodynamic analysis: The Phonatory Aerodynamic System Model 6600 by KayPentax was
used for the aerodynamic measurements (300 ml pneumotachograph - System requirements same
as CSL model 4500). Airflow measures were taken using an airflow mask and a
pneumotachograph, which uses the principle of differential pressure across a known resistance to
estimate airflow rate.
Statistical analysis
Statistical analyses were performed using SPSS ver.22. Statistical analyses included
descriptive statistics, frequencies and comparisons between the radiation therapy (RT) and control
groups. Comparisons for continuous variables between the two groups were performed using
independent sample t-tests and Mann-Whitney U-tests depending on normality of distribution.
Continuous variables included CAPE-V measures, VHI scores, acoustic measures (jitter,
shimmer, Noise to Harmonic Ratio, Maximum Phonation Time, pitch range and CSID measures).
Comparisons for non-continuous variables between the two groups were performed using a
Fisher’s exact test. Non- continuous variables included stroboscopic and high speed parameters.
Significance levels were set at 0.05.
Results
Descriptive statistics: A total of 18 participants were recruited for the study (RT=10, control=8).
The RT group consisted of seven males and three females, and the control group consisted of six
males and two females. The mean age of participants in the RT group was 66.1 years (standard
deviation:12.96) and the mean age of participants in the control group was 55.5 years (standard
deviation: 13.8). In terms of smoking status, the RT group consisted of six former smokers, two
current smokers, and two non-smokers. Nine participants in the RT group had a history T1 glottic
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cancer and one participant had a history of T2 supraglottic cancer. The control group consisted of
three former smokers, four current smokers and one non-smoker. In terms of smoking habits, the
mean pack years in the RT group was 37.9 years (standard deviation: 38.91) and control group
was 41.38 years (standard deviation= 26.62). For the RT group, time from completion of
radiation therapy ranged from 24 – 84 months. Descriptive statistics for participant demographics
are available in Table 4.2.
Prior to comparisons of vocal function parameters, the two groups under study were
compared for age, sex and pack years of smoking. The two groups were closely matched in sex
distribution. Results from independent sample t-tests showed no significant differences between
the two groups in terms of age (p= 0.118) or pack years of smoking (p= 0.825).
Results from continuous variables: The two groups differed significantly for; CAPE- V
parameters of overall severity (p=0.11) (Table 4.4), loudness (p=0.012) (Table 4.5), breathiness
(p=0.001) (Table 4.4), roughness (0.008) (Table 4.4) and strain (p=0.007) (Table 4.5), Voice
Handicap Index-Physical domain (p= 0.036) (Table 4.7), pitch range (p= 0.045) (Table 4.10) and
mean peak air pressure/PSub (p= 0.01) (Table 4.13) .
Overall abnormal clinical values were seen in the RT group as observed in their mean
scores for CAPE-V overall severity (29.4) (Table 4.3), CAPE-V loudness (29.9, SD: 13.74 )
(Table 4.3), CAPE-V breathiness (32, SD: 12.4) (Table 4.3), CAPE-V roughness (31.7,
SD:15.48) (Table 4.3) and CAPE-V strain (36.1, SD: 12.7) (Table 4.3); overall VHI scores (22.6,
SD: 13.5) (Table 4.6); jitter percentage (2.14) (Table 4.9), shimmer dB (0.68) (Table 4.9), noise
to harmonics ratio (0.209) (Table 4.9), CSID /a/ (23.79) (Table 4.9), CSID for easy onset stimulus
(18.62) (Table 4.9), CSID for voiceless plosive stimulus (19.43) (Table 4.9), CSID for hard
glottal attack stimulus (19.59) (Table 4.9); Psub (9.08, SD: 2.41) (Table 4.12), laryngeal airway
resistance (74.69, SD: 84.6) (Table 4.12) and phonation threshold pressure (5.9, SD:3.25) (Table
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4.12). Means and standard deviations for all continuous variables under study are available in
Tables 4.3 to 4.12.
Results from non-continuous variables: Clinically abnormal findings were seen across majority
of stroboscopic and high speed parameters under study for both groups. High speed laryngeal
imaging could not be performed on two participants from the RT group and one participant from
the control group due to participant difficulty tolerating the presence of a rigid endoscope.
However, the RT group showed a higher percentage of participants with abnormal stroboscopic
and high-speed parameters. Percentage of participants who demonstrated abnormal stroboscopic
and high-speed parameters is displayed in tables 4.15 and 4.17 respectively. The control group
showed a higher percentage of abnormal findings only for the parameters of phase symmetry
(Table 4.15). However, the two groups under study only showed a statistical significant
difference for amplitude of vibration for stroboscopic examination (p=0.009) (Table 4.16). No
significant differences were observed between the two groups for any of the high speed
parameters (Table 4.18).
Discussion
Previous studies have demonstrated that radiation therapy negatively affects voice
quality;9,30,77,81 however these studies have examined limited voice outcome measures. As a result
it is difficult to characterize vocal function issues following radiation therapy in a comprehensive
manner. The present study confirmed findings from previous studies since it demonstrated that
patients exhibited abnormal vocal function across various voice parameters following radiation
therapy. Interestingly, participants in the radiation group were 24-84 months post-completion of
radiation therapy and continued to exhibit clinically abnormal values in voice parameters, further
highlighting the long-term and in some cases permanent deleterious effects of radiation toxicity
on voice quality. However, the aim of the present study was to characterize vocal function
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beyond simply one parameter by examining the five domains of voice assessment. Participants in
the RT group were also compared to participants who were matched in terms of sex, age and
smoking habits to account for changes to the vocal mechanism that take place as a result of these
factors. The results from the present study are discussed in detail in the next section with
reference to each of the domains of voice assessment.
Domain I- Auditory perceptual measures (Tables: 4.3,4.4,4.5)
The present study compared CAPE-V scores between the two groups under study. The
assessor for CAPE-V is a licensed and certified speech-language pathologist with over 40 years
of experience in the field of voice disorders. The assessor was blinded to group assignments.
CAPE-V scores in the radiation therapy group were consistently worse as compared to the control
across all CAPE-V parameters except for pitch (overall severity, loudness, breathiness, roughness
and strain). For parameters of overall severity, roughness and strain, CAPE-V scores were in the
clinically abnormal range for both groups, but were higher in the RT group, which is indicative of
a greater degree of dysphonia. The control group showed mild dysphonia across overall severity,
roughness and strain, and the RT group showed moderate dysphonia across the same parameters.
Similar findings were reported in studies by Bergstorm, et.al, Hocevar, et.al and Sjoren, et.al.8,13,81
Scores for loudness and breathiness were within normal limits for the control group, whereas the
RT group showed scores that demonstrated moderate levels of dysphonia. Statistically, the groups
differed across all parameters except for pitch. These findings demonstrate that the voice quality
of participants who had been irradiated sounded distinctly abnormal and moderately dysphonic to
an experienced listener as compared to a control group of participants who were matched in age,
sex and pack years of smoking.
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Domain II- Patient self assessment (Tables: 4.6,4.7,4.8)
The present study compared Voice Handicap Index scores between the two groups under
study. Participants in the RT group had higher total scores (mean: 22.6, SD: 13.5) as compared to
the control group (mean:11.63, SD: 12.68) indicative of a greater level of voice handicap.
However, in the RT group, these scores were in the clinically abnormal range only for the
physical domain of voice handicap (mean: 13.3, SD: 9.4).47 Each of the domain scores for
participants in the control group was within clinically normal limits. The physical domain of the
voice handicap index represents self-perceptions of laryngeal discomfort and voice output
characteristics.47 Findings of reduced scores on voice-related quality of life were consistent with
findings on studies by Karlsson, et.al and Cohen, et.al.17,193 These results indicate that individuals
continue to experience challenges related to voice use following radiation therapy. Participants in
the RT group consistently rated high levels of impairment on the following statements:
1) I feel as though as I have to strain to produce voice
2) I use a great deal of effort to speak
3) My voice sounds creaky and dry
4) The sound of my voice varies throughout the day
5) The clarity of my voice is unpredictable
6) My voice gets worse in the evening
These findings are reflected in the CAPE-V scores, as voices of participants in the RT group were
described as having increased roughness, increased breathiness and increased strain.

54

Domain III- Acoustic analysis (Table 4.9,4.10,4.11)
Comparisons were made between two groups for measures of jitter, shimmer, noise to
harmonics ratio, pitch range, maximum phonation time and CSID measures. The RT group
demonstrated clinically abnormal values on sustained vowel /a/ for measures of jitter (mean: 2.14,
SD: 2.61), shimmer (mean: 0.68, SD: 87) and Noise to Harmonic Ratio (Mean: 0.209, SD: 0.21).
These values were within clinically normal limits for the control group. For connected speech and
sustained phonation when analyzed using the Analysis of Dysphonia for Speech and Voice
(ADSV), CSID (Cepstral Speech Index of Dysphonia) values were higher in the RT group across
all sentence types (easy onset- EOS, all voiced- AVS, voiceless plosives- VPS and hard glottal
attacks-HGAS) as compared to the control group. These values were also in the clinically
abnormal range for all parameters with the exception of VPS in the RT group. These parameters
were within normal limits in the control group. Pitch range in the RT group was also lower as
compared to the control group. Average maximum phonation times between the two groups only
differed by three seconds. Values of increased perturbation measures are consistent with findings
of studies by Tamura et.al and Wedman, et.al.78,79 However, even though these values fell within
the clinically abnormal range for the RT group, the only measure that demonstrated statistically
significant differences between the two groups was pitch range (p= 0.045). Elevated perturbation,
noise measures and CSID values further describe the dysphonia perceived in the auditoryperceptual analysis. Increased perturbation, noise and CSID measures can be associated with
increased roughness and breathiness heard on the auditory-perceptual analysis. An increase in
these measures is also reflected in the patients’ perception of their voices on the VHI when they
describe their voices as sounding “creaky or dry.”
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Domain 4: Aerodynamic measures (Tables 4.12,4.13,4.14)
Aerodynamic measures of mean peak air pressure, laryngeal airway resistance, mean
airflow during voicing and phonation threshold pressure were compared between the two groups.
Clinically abnormal values were seen in the RT group for measures of mean peak air pressure
(mean: 9.08, SD: 2.41), laryngeal airway resistance (mean: 74.69, SD: 84.7) and phonation
threshold pressure (mean: 5.93, SD: 3.25). Findings of elevated peak pressure and airway
resistance values are consistent with findings of studies by McGuirt, et.al and Tamura, et.al.12,79
These values were within normal limits in the control group. The control group showed clinically
abnormal values for airflow rate (mean: 0.205, SD: 0.29); average airflow rate was within normal
limits for the RT group. Although these values were in the clinically abnormal range, the only
parameter that demonstrated statistically significant difference between the two groups was Psub
(p=0.01). Increased resistance, Psub and phonation threshold pressure values are suggestive of the
presence of increased effort and hyperfunctional voice use in the RT group .198 The increase in
Psub and LAR values is also indicative of increased stiffness offered by edematous vocal
folds.65,198 These elevated clinical values are reflected in the strain scores of the CAPE-V, as well
as in the responses of participants on select VHI items (“I feel as though I have to strain my
voice,” “I use a great deal of effort to speak”).
Domain 5: Visual perceptual measures or laryngeal imaging (Tables 4.15,4.16,4.17,4.18)
Laryngeal imaging was performed using laryngeal stroboscopy and high speed laryngeal
imaging. Visual perceptual ratings were performed by a licensed and certified speech- language
pathologist with over 40 years experience in voice disorders. The assessor was blinded to the
groups under study. Comparisons on both methods of visualization were made on parameters of
glottic closure, mucosal wave, amplitude of vibration, phase asymmetry and presence or absence
of hyperfunction. Qualitative assessments were made on the overall appearance of the laryngeal
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mechanism (dehydrated appearance, edema) and true vocal folds (erythema, edema,
hypervascularity or combination of erythema, edema and hypervascularity) considering the
structural damage to the laryngeal tissues following RT, as well as exposure to tobacco and age
related changes. Between the two groups, the RT group demonstrated a higher percentage of
participants with clinically abnormal findings for mucosal wave (90%), amplitude of vibration
(100%) and phase symmetry (70%). Both groups showed a high percentage of participants with
presence of hyperfunction (100% in both groups). The overall appearance of the larynx was
judged as being abnormal (dehydrated and erythematous) in 70% percent of participants in the
RT group as compared to 37.5% percent (erythema only) in the control group. Similar findings
were noted for appearance of the true vocal folds, where eighty percent of the participants in the
RT group were judged as having some abnormality of the true vocal folds and these abnormal
findings were noted on the primary cancer site as well as on the vocal fold unaffected by cancer.
The abnormal findings of overall laryngeal appearance and changes on the unaffected vocal fold
as a result of XRT further highlight the collateral damage caused due to radiation toxicity. These
findings are consistent with studies by Wedman et. al,78 Tamura, et.al79 and Mintz, et.al.9
High speed laryngeal imaging was found to be a more effective tool for judging vocal
fold vibratory parameters. There was a decrease in abnormal findings when judging vocal fold
pliability (mucosal wave and amplitude) in both groups on high speed imaging. There was
increase in abnormal findings in RT group for glottic closure judgement using high speed
imaging. The overall level of dysphonia was higher in the RT group, making stroboscopic
parameters less reliable due to tracking errors.199 This is consistent with findings in previous
studies which have favored the use of high speed laryngeal imaging in judging vocal fold
vibratory parameters in patients with highly dysphonic voices.199
As demonstrated by the results above, one or more parameters in each domain of voice
assessment was found to be clinically abnormal in the RT group. The control group demonstrated
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abnormal findings for the domains of laryngeal imaging (100% showed hyperfunction) and one
parameter of the aerodynamic domain (airflow rate). The present study demonstrates the effect of
radiation toxicity on vocal function holistically. The present study shows that physiological and
psychosocial domains of vocal function are affected following XRT and continue to be affected
for several years after completion of XRT. Considering that XRT has a significant negative
impact on vocal function, voice rehabilitation following XRT is important, which is the focus of
the next chapter.
Limitations
For our present study, we were not successful in accruing the target sample size.
However, our groups were well matched in age, sex and pack years of smoking. Our study had
certain limitations that need to be addressed. Since we were addressing issues of vocal function as
a result of XRT, we did not perform pre-XRT voice assessments. However, pre-XRT assessments
would be helpful in identifying the deterioration in vocal function as a result of laryngeal cancer
itself and then comparing these deficits with those seen as a result of XRT to gain a more holistic
picture of the individual’s experience. Another limitation was the variation in the RT group itself
between early and late stage cancers. A majority of the group was early stage glottic cancers and
our participant with advanced cancer had a history of supraglottic cancer. For future studies,
equally distributed groups in terms of stage and site are suggested within groups. Stratification of
site and stage is also suggested since individuals with advanced laryngeal cancers also receive
chemotherapy. Future studies may seek to identify changes in vocal function as a result of
chemotherapy compared to XRT alone.
The next chapter focuses on stage 3 of this dissertation, which consisted of investigating
the efficacy of an evidence based voice rehabilitation method (Vocal Function Exercises) in
adults who had undergone XRT.
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CHAPTER 5: STUDY 3
Study title: Investigating the efficacy of Vocal Function Exercises in improving voice production
in adults irradiated for laryngeal cancers
Chapter 5 describes Stage III of the dissertation study in detail. As described in previous
chapters, vocal function is negatively affected following radiation therapy for laryngeal cancers.
As observed in previous studies, and as demonstrated in Stage II of this dissertation, multiple
dimensions of vocal function are affected as a result of radiation therapy. These changes are
chronic in most cases and can cause significant voice-related quality of life issues. Though postradiation voice problems are a well-established clinical entity, there is an observable dearth of
evidence into investigating the rehabilitation of these voice disorders. At present, there is no
standardized approach to voice rehabilitation in patients irradiated for laryngeal cancers. The
objective of the present study was to investigate the efficacy of a systematic evidence-based
approach to improving vocal function following radiation therapy for laryngeal cancers. The next
few sections inform the reader on background, study methodology, and results of the present
study. This chapter also includes a detailed discussion of the study findings.
Background
The curative role of radiation therapy (XRT) in the treatment of laryngeal cancers is well
documented. Since the 1990s, increasing numbers of patients with laryngeal cancers have been
treated primarily with radiation therapy, with or without chemotherapy, with the intent of
preserving laryngeal structure and function. Early laryngeal cancers can be treated with XRT
alone, while advanced laryngeal cancers are treated with a combination of chemotherapy and
radiation therapy. 2,3 However, collateral damage to the laryngeal and oral structures caused by
radiation toxicity absent chemotherapy is a well-documented clinical entity.6-9 These prolonged,
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and in some cases, permanent voice and swallowing problems post-radiation are indicators that
preserving laryngeal structure is not translating into preserving laryngeal function.
Radiation damage to the larynx results in edematous and dehydrated tissues, leading to
excessive compensatory compression of laryngeal structures during phonation, thus affecting
vocal fold vibratory characteristics.8,10-12 Another characteristic feature of radiation toxicity is
delayed onset of injury.10 Consequently, following these acute changes to the laryngeal
mechanism, ongoing negative changes occur as a result of radiation toxicity. Acute and long-term
deterioration in voice quality post-radiation may lead to significant communication deficits in
daily life or in some cases may result in loss of livelihood. Therefore, voice rehabilitation postradiation therapy is relevant consideration and warrants attention. Unfortunately, there is a
paucity of research with respect to voice rehabilitation in the irradiated population. Only four
studies have investigated the efficacy of voice therapy in post-radiated laryngeal cancer patients
with no recommended standardized treatment.13-16 The two studies conducted in patients
irradiated for early glottic cancers did not describe the type of voice therapy used; however the
study did demonstrate that voice therapy was successful in improving perceptual voice quality
and voice-related quality of life.15,16 Two other studies investigated the efficacy of voice therapy
when utilized post-radiation for not only early but also advanced laryngeal cancers.13,14 In both
studies, patients showed a greater improvement in voice quality as measured by auditoryperceptual measures and voice-related quality of life as compared to a control group. The voice
therapy interventions across these four studies, however, were varied and not specified.
According to these publications, the authors used direct and indirect voice interventions, ranging
from tasks such as breathing, relaxation, and posture adjustment to specific physiology-targeted
phonation exercises. However, the studies do not assert whether or not one of these methods was
more efficacious than the others. In addition, only two dimensions of vocal function – perceptual
quality and voice-related quality of life self-assessment - were used to measure improvement in
both studies, instead of a more comprehensive voice assessment method.
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Central to treatment approaches in the above studies was vocal hygiene (VH) counseling.
13-16

However, results of outcomes research related to VH demonstrate that this form of therapy

may be more effective when coupled with a more exercise-intensive physiologic voice therapy
approach.20 The Vocal Function Exercise (VFE) program is one such evidence-based physiologic
approach to voice therapy. VFEs include a series of isometric and endurance-based exercises
aimed at strengthening laryngeal musculature, improving vocal fold vibratory characteristics, and
balancing the three sub-systems of voice production: respiration, phonation and resonance.22
Although VFEs have been employed successfully in treating a variety of voice disorders, the
efficacy of this approach for improving voice quality in adults following laryngeal radiation has
not been investigated.18,19,22,23 The success of VFEs with various voice disorders has led to the
principal question of the present dissertation:
Research question: Is the Vocal Function Exercise program efficacious in improving voice
production in adults radiated for laryngeal cancers?
The following specific aims were addressed in Stage III of the dissertation:
Specific aims
Specific aim 1: To investigate the efficacy of Vocal Function Exercises (VFE) for improving
voice production in adults irradiated for larynx cancers as demonstrated by change in pre- and
post-intervention Voice Handicap Index scores. The present stage was designed as a Phase 2
clinical trial with Voice Handicap Index being the primary outcome measure. Secondary outcome
measures include laryngeal stroboscopy, high-speed laryngeal imaging, acoustic analysis,
aerodynamic analysis and auditory-perceptual measures. Participants were randomly assigned to
one of two groups: VFE and vocal hygiene (VFE+VH), and vocal hygiene (VH) alone. VH was
used as the comparison treatment group since previous studies have utilized vocal hygiene as a
treatment approach for patients irradiated for laryngeal cancers. We hypothesize that the VFE +
VH group will demonstrate significantly greater improvement in pre- and post-treatment Voice
Handicap measures as compared to the VH only group.
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Specific aim 2: To investigate the efficacy of Vocal Function Exercises (VFE) for improving
voice production in adults irradiated for larynx cancers as demonstrated by improvement in select
parameters from the five domains of voice assessment. Outcome measures from the five domains
of voice assessment include patient self- assessment, auditory-perceptual measures, acoustic
analysis, aerodynamic analysis, laryngeal stroboscopy and high-speed laryngeal imaging. We
hypothesize that the VFE + VH group will demonstrate a larger proportion of participants with
an improvement across all five domains as compared to the VH only group.
The next section describes our study methodology in detail which addresses the specific
aims stated above.
Methods
Participants for Stage III were recruited from the multidisciplinary head and neck cancer
clinic at the Markey Cancer Center (University of Kentucky) following approval from the
Institutional Review Board (IRB) at the University of Kentucky (UK). Sample sizes of 8 in each
group achieve 80% power to detect a difference in VHI (pre and post intervention) of 14.3 in the
voice therapy group and 0.5 change in vocal hygiene group.16 An n of 16, with 8 participants in
each group was determined considering VHI change and a common standard deviation equal to
11.6, a significance level (alpha) of 0.1, and a two-sided z-test.16 These results assume that 2
sequential tests are made using the O'Brien-Fleming spending function to determine the test
boundaries. Stage III was designed as Phase 2 clinical trial. Participants were randomly assigned
to one of two groups: VFE+VH (Vocal Function Exercise + Vocal Hygiene) or VH (Vocal
Hygiene).
Participants
After completion of informed consent, 12 participants were recruited for the study.
Participants in both groups met the following inclusion criteria; adults over 18 years of age,
previously irradiated for laryngeal cancer (with or without chemotherapy), hearing levels
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appropriate to follow directions, and deemed cancer-free by the treating physician at the time of
study recruitment. Participants had to have completed XRT at least 6 months prior to study
participation. Presence of vocal fold paralysis or surface vocal fold pathology at the time of study
recruitment constituted exclusion from the study.
Assessment battery
Participants in both groups underwent the same multidimensional vocal assessment
battery. The battery included assessment protocols belonging to the five domains of voice
assessment and was the same assessment battery used for Stage II of the dissertation. A checklist
for the assessment battery is available in Appendix I. The five common domains of voice
assessment are: auditory-perceptual measures, patient self-assessment, acoustic analyses,
aerodynamic analyses, and laryngeal imaging or visual-perceptual assessments. Outcome
measures and their normative values are available in Table 4.1. Outcome measures are listed
below with reference to each domain of voice assessment.
5) Auditory- perceptual assessment: The Consensus Auditory-Perceptual Evaluation of Voice
(CAPE-V- Appendix II) was utilized. Blinding: Audio samples of patients’ voices reading the
rainbow passage (Appendix III) were presented to a licensed and certified speech-language
pathologist with over 40 years of clinical experience in the field of voice disorders. The
assessor was blinded to group assignments.
6) Patient self-assessment: Voice Handicap Index (Appendix IV) was utilized. Total scores and
domain specific scores (Physical, Functional, Emotional) were included for final analysis.
7) Acoustic analyses: The Multidimensional Voice Profile (MDVP) and Analysis of Dysphonia
in Speech and Voice (ADSV) were utilized. Specific measures included jitter, shimmer, noise
to harmonics ratio (NHR), maximum phonation time (MPT) and pitch range for MDVP; and
Cepstral Spectral Index of Dysphonia (CSID) was used for ADSV stimuli.197 CSID included
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sustained vowel and sentence stimuli. Sentences included easy onset, voiceless plosive, all
voiced and hard glottal attacks.
8) Laryngeal imaging/visual perceptual assessment: Measures included were laryngeal
stroboscopy and high-speed laryngeal imaging. Stroboscopic and high-speed features were
rated on a scale (Appendix V). Stroboscopic and high-speed parameters include glottic
closure, mucosal wave, amplitude of vibration and phase symmetry. Ratings were performed
by a licensed and certified speech-language pathologist with over 40 years of clinical
experience in the field of voice disorders. The speech-language pathologist was blinded to
group assignment.
Instrumentation
1) Laryngeal stroboscopy: Laryngeal stroboscopy was performed using the Kay Elemetrics
Rhino-Laryngeal Stroboscope – (Model RLS 9100 B, Halogen lamp: 150 watts, Xenon lamp: 120
watts, frequency range: 60 Hz – 1000 Hz, laryngeal microphone), a Kay Elemetrics 70 degree 22
rigid scope (Model 9106, total length: 252 mm), Kay distal endoscope, and a C-mount camera
(Panasonic 3CCHD).
2) High-speed digital imaging: For the HSDI recordings, a KayPentax high-speed system model
9710 was used. Images were recorded at 4000 frames/s for a maximum duration of 4 seconds
with a spatial resolution of 5123256 pixels. A 300W Xenon light source was used.
3) Acoustic analysis: For acoustic assessment, the Computerized Speech Lab Model 4500 by
KayPentax was used with a hand-held microphone (mouth-to-microphone distance = 3 inches)
[System Requirements: Analog Inputs: 4 channels: two XLR and two phono-type, 5mV to 10.5V
peak-to-peak, adjustable gain range >38dB, 24-bit A/D, Sampling Rates: 8,000-200,000Hz,
THD+N: <-90dB F.S. Frequency Response (AC coupled): 20-22kHz +.05dB at 44.1kHz. Digital
Interface: AES/EBU or S/P DIF format, transformer-coupled. Software Interface: ASIO and
MME. Computer Interface: PCI (version 2.2-compliant), PCI card; 5.0" H x 7.4" W x 0.75" D
(half-sized PCI card). Analog Output: 4 channels, line and speaker, headphone output, channels 1
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& 2 provide line & speaker outputs. Physical: 4" W x 8.25" H x 12.5" D, 4 lbs. 12 oz., 45 watts,
speaker, and microphone (Shure SM-48 or equivalent, XLR-type)].
4) Aerodynamic analysis: The Phonatory Aerodynamic System Model 6600 by KayPentax was
used for the aerodynamic measurements (300 ml pneumotachograph - System requirements same
as CSL model 4500). Airflow measures were taken using an airflow mask and a
pneumotachograph, which uses the principle of differential pressure across a known resistance to
estimate airflow rate.
Study Interventions
Participants were randomized to one of two intervention groups based on a pre-determined
randomization protocol. Participants were randomized to the VH group or VFE + VH. Each
intervention lasted for 6 weeks. The two intervention methods are described in detail below:

I)

Vocal hygiene counseling: Vocal hygiene counseling involved educating and informing
patients regarding factors that influence voice use and voice care. Sessions generally
revolved around strategies that enhance and maintain vocal health. These include tips on
healthy voice use, hydration and dietary modifications required to maintain a healthy
vocal system. Post-radiation vocal hygiene counseling stressed hydration and dietary
considerations since significant changes in salivary status and tissues are noted during
this period.

II) Vocal Function Exercises: Vocal Function Exercises (VFEs) are a series of isometric and
endurance-based exercises which aim at strengthening and balancing the three sub-systems
of voice production, specifically respiration, phonation and resonance. VFEs also aim
directly at strengthening vocal fold musculature thus improving their vibratory
characteristics. The exercises program consists of a series of four exercises which include a
warm-up, vocal fold stretching, vocal fold contraction and endurance exercise. The warmup and endurance exercises are timed (in seconds) and performed on strategically
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determined musical notes. The VFE program for the proposed study lasted 6 weeks where
the patient was required to perform the exercises twice a day, every day. As a result, these
exercises relied heavily on compliance.
Treatment plan: Specific treatment plans are described below in detail:
Vocal hygiene group: During the pre-intervention assessment, each study participant attended a
session on voice care with a licensed and certified speech-language pathologist trained
specifically in the care of patients with laryngeal cancer. Participants were also provided with
handouts with tips about vocal hygiene. Participants followed up 6 weeks later to undergo postintervention assessments. Participants in the VH group were seen a total of 2 times (preintervention and post-intervention). Appendix VI contains details regarding the Vocal Hygiene
Handout.
VFE + VH group: During the pre-intervention assessment, each study participant attended a
session on voice care with a licensed and certified speech-language pathologist trained
specifically in the care of patients with laryngeal cancer. Participants were also provided with
written handouts that included tips on vocal hygiene. Participants were then taught Vocal
Function Exercises (VFEs) by the same speech-language pathologist trained in the administration
of VFEs (Please refer to Appendix VII for description and log sheets for VFEs). Participants were
given an audio CD with the VFEs as well as log sheets to track their maximum phonation times
during twice-daily exercise. Patients were monitored through weekly in-person or distance
sessions to monitor both technique and progress. They underwent the above described
assessments at the beginning of therapy and after 6 weeks of exercises.
Statistical analysis
Statistical analyses were performed using SPSS ver.22. Statistical analyses included
descriptive statistics, frequencies and comparisons between VFE+VH and VH only groups.
Comparisons for continuous variables between the two groups were performed using paired t66

tests. Continuous variables included CAPE-V measures, VHI scores, acoustic measures (jitter,
shimmer, Noise to Harmonic Ratio, Maximum Phonation Time, pitch range and CSID measures).
Comparisons for non-continuous variables between the two groups were performed using the
McNemar’s test. Non-continuous variables included stroboscopic and high-speed parameters.
Significance levels were set at 0.1.
Results
Following completion of informed consent, 12 participants were recruited for the study.
However, one participant from each group had to be excluded from the study. The participant
from the VFE+VH group opted out of the study citing personal reasons. The participant from the
VH group had concerning findings for recurrent disease during her routine follow-up visit. She
underwent biopsies which were negative for recurrent disease. Data from 10 participants were
included for the final analysis.
The mean age in the VH group (n=4) was 69 years (SD: 5.34) and the mean age in the
VFE+VH group (n=6) was 57.5 years (SD: 14.2). All participants in the VH group had a history
of early glottic cancer and had received narrow field radiation therapy as treatment. The VFE+VH
group consisted of three participants with early glottic cancer and three participants with
advanced stage glottic (n=1) and supraglottic cancer (n=2). Three participants with a history of
early glottic cancers had received narrow field radiation therapy (XRT), while participants with a
history of advanced laryngeal cancers had received wide field radiation therapy and adjuvant
chemotherapy. Time since completion of XRT for the VH group ranged from 18 months to 48
months. Time since completion of XRT in the VFE+VH group ranged from 24 months to 84
months. The VH group consisted of two current smokers and two former smokers. Five
participants in the VFE+VH group were non-smokers and one participant was a former smoker.
The average pack years of smoking in the VH group was 70 pack years (SD: 43.97) and in the
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VFE+VH group was 33.5 pack years (SD: 40.25). Patient demographics and characteristics are
available in Table 5.1.
As stated above, participants in each group underwent the entire assessment battery at
pre-intervention and at 6 weeks. Participants in the VFE+VH group underwent in-person or face
to face (distance: Skype/Facetime) therapy weekly. Participants in the VH group were seen only
at the pre-intervention and post-intervention session. The numbers of sessions attended by
participants of the VFE+VH group are presented in table 5.2. The table also informs the reader on
the adherence to the entire VFE protocol. Traditionally, VFE activities are to be performed two
times each, twice a day (2x2). However, only three participants performed the entire VFE
protocol (2x2). Three participants performed the VFE protocol only two times each, once per day
(2x1). Three participants attended voice therapy with the principal investigator (in person) at UK.
Three participants received voice therapy over Skype or Facetime (distance) with the principal
investigator. In addition, participants in the VFE+VH group also received VFE exercises on an
audio CD.
The next sections will discuss results related to pair wise comparisons for continuous
variables by group.
Paired t-tests
Paired t-test results in the present section will be discussed according to the five domains
of voice assessment. For ease of discussion, only statistically significant results are presented in
this section. Means and standard deviations for all parameters under study for the two groups are
available in tables 5.3 – 5.13.
Patient self-assessment: Overall a decrease in VHI scores was seen across all domains in both
groups; however pre and post VHI scores were significant for the physical domain (p=0.03) in the
VFE+VH group (Table 5.3). Pre and post VHI measures were not statistically significant for any
of the VHI scores in the VH group (Table 5.4).
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Auditory-perceptual measures: An overall decrease in CAPE-V scores was observed across all
CAPE-V parameters in both groups (Table 5.5,5.6). However, pre and post CAPE-V parameters
were statistically significantly different for the CAPE-V overall severity score only in the
VFE+VH group (Table 5.5). CAPE-V parameters in the VH group did not approach statistical
significance.
Acoustic analysis: An overall improvement in acoustic parameters was observed across both
groups (Tables 5.7, 5.8). In the VFE+VH group, the average CSID for easy onset sentences
(EOS) showed an increase in scores which indicates a worsening in this parameter. The VFE+VH
group showed statistical significance for improvements in pitch range and maximum phonation
time (Table 5.7). The VH group values did not approach statistical significance across any of the
parameters (Table 5.8).
Aerodynamic analysis: Overall trends for aerodynamic measures were highly varied for both
groups under study. The VFE+VH group demonstrated a statistically significant pre-post
difference for subglottic pressure (PSub) (Table 5.9). The VH group did not show statistical
differences across any aerodynamic parameters (Table 5.10).
Laryngeal imaging (Stroboscopic and high-speed parameters): Pre to post changes were seen
for stroboscopic parameters of mucosal wave, amplitude and phase symmetry in the VFE+VH
group (Tables 5.11). The VH group did not show any pre-post change on stroboscopic parameters
(Table 5.12). On high speed imaging, changes were observed pre-post for amplitude of vibration
in the VFE+VH group (Table 5.13). The VH group did not show any pre-post changes on high
speed parameters (Table 5.14).
A challenge that we faced through the present data analysis was the high variability seen
in the data, which was compounded by our low sample size. To make our data more
comprehensive, Table 5.15 provides an analysis of improvement by participant. If an
improvement was seen in one or more parameters of one domain, the domain column was marked
with an ‘+’. Table 5.15 provides the number of improved domains for each participant at post69

intervention assessment. Overall, none of the participants in the VH group showed an
improvement across all five domains. Three participants in the VFE+VH group showed
improvements across select parameters in all five domains of voice assessment. However, for our
primary outcome measure of VHI, improvements were made in both groups across all but one
participant in each group.
Discussion
Previous studies have demonstrated improvements in voice-related quality of life and auditoryperceptual measures of voice as a result of voice therapy interventions following radiation
therapy for laryngeal cancers.13-16 The present study supported these previous findings since
greater improvement was noted in the VHI physical domain and the CAPE-V measures for
overall severity in the VFE+VH group as compared to the VH only group. Statistically significant
differences were also seen in the VFE+VH group for parameters of pitch range (acoustic
analysis), MPT (acoustic analysis) and Psub (aerodynamic analysis). The VH group did not show
statistically significant changes across any of the parameters, further strengthening previous study
findings that VH alone is not highly effective in improving voice quality and but rather is most
useful when paired with a physiologic voice therapy approach.20 To account for the high
variability of data seen in the present study, we also performed an analysis accounting for the
improvement seen in each domain by each of the study participants. This analysis demonstrated
that 50% of participants in the VFE+VH group showed improvement across all five domains of
voice assessment, while 0% of participants in the VH group showed improvement across all five
domains. However, for our primary study outcome, VHI, an improvement was seen across all but
one participant in each group. Though none of the improvements in VHI in the control group
were statistically significant, it is possible that participants were more aware of voice care
strategies, and as a result, experienced an improved voice-related quality of life. The use of VH
therefore cannot be discounted in the present study population. Not surprisingly, study
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participants who completed the full VFE protocol improved across all domains of voice
assessment. This supports previous study findings by Nguyen et.al.106 who demonstrated that
individuals who completed the full VFE protocol showed the largest magnitude of improvement
as compared to individuals who completed the partial VFE protocol. However, these results were
demonstrated in individuals with no prior history of radiation therapy for HNC. Our findings
showed pre to post intervention changes in the VFE+VH group for mucosal wave, amplitude and
phase symmetry on stroboscopy. No changes were seen for laryngeal imaging studies
(Stroboscopy and high speed) in the VH group. However, the judgement of laryngeal imaging
parameters was challenging due to the generalized abnormality of laryngeal structures that occur
as a result of XRT. Although certain stroboscopic and high speed parameters improved, the prepost results did not shift from abnormal to normal. This is in agreement with the objective voice
parameters obtained at the post intervention period for both groups. Although an improvement
was observed in objective parameters such as CAPE-V, acoustics and aerodynamics, not all
participants approached normative clinical values. Clinically, these findings are significant since
it is quite possible normal voice production or normative clinical values may not be a realistic
goal in this population. Ideally, the clinical goal should be targeted towards improvement and
overall functionality of voice production. From our previous chapter, it is evident that high-speed
laryngeal imaging was a better assessment tool for assessing vocal fold vibratory features, and we
still advise clinicians to use it as an assessment tool for this population. Subglottic pressure
measures appear to be affected the greatest in this population. All participants in the study
demonstrated elevated Psub levels, which is reflective of the chronic edematous changes that
occur in the irradiated larynx.9,12,14 Elevated Psub levels persisted even after completion of both
interventions.
In conclusion, VFEs in combination with vocal hygiene were found to be effective in improving
vocal function across all five domains of voice assessment in 50% of our study participants.
Vocal hygiene alone was not found to be effective in improving vocal function across all five
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domains in any of the study participants. Even though these findings are difficult to generalize
due to our limited sample size, these study findings serve as promising pilot data in demonstrating
the utility of VFEs in individuals irradiated for laryngeal cancers.
Limitations
We were unsuccessful in accruing our required sample size as dictated by the power analysis.
One of the greatest challenges for our study participants in both groups was travel distances with
distances ranging from 80 miles (Somerset, KY) to a 115 miles (Hazard, KY). When given the
option for voice therapy over Facetime or Skype, we experienced issues with insufficient
computer literacy and lack of smartphone/computer accessibility. For future studies, the option of
organized telehealth for a cost-effective method of delivery of voice therapy should be explored.
The issue of availability for voice therapy can also be resolved by changing the time of
recruitment. In the present study, participants were recruited 6 months after the completion of
XRT. At this time, patients only make visits to their treating physician at a 6-month intervals. For
future studies, patients may be recruited during XRT intervention since they need to be present at
the medical center every day for 6 weeks throughout the treatment. Another limitation of the
study was the discrepancy in the degree of attention to treatment received by the participants in
the VH only group versus the VFE+VH group. The VH group received only one in-person
session on vocal hygiene counseling which is a typical clinical practice across most centers.
Participants in the VFE+VH group were seen in person or via distance weekly and could address
any questions that participants had pertaining to vocal hygiene. As a result, it is possible that
participants in the VFE+VH group were more adherent to their vocal hygiene routine as well,
secondary to increased contact with the treating professional (SLP). For future studies, the VH
group ideally should receive weekly check-in sessions as well to monitor adherence.
The next chapter provides the reader with a synthesized discussion on the three stages of
the dissertation study.
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CHAPTER 6: SYNTHESIZED DISCUSSION
The principal focus of this dissertation was to investigate the efficacy of Vocal Function
Exercises (VFEs) in adults irradiated for laryngeal cancers. This investigation was performed in
three systematic stages that are listed below.
Stage 1: This stage involved identifying patients who had been irradiated for laryngeal cancers at
the University of Kentucky (UK). However, considering the rising incidence of head and neck
cancers in Kentucky, we extended the study to all head and neck cancers (HNC). In addition to
helping identify our study population, this study stage was helpful in highlighting the head and
neck cancer burden in Kentucky, with a special focus on Appalachian Kentucky.
Stage 2: Disorders of voice production as a result of radiation therapy are a well-documented
clinical entity. However, few studies have performed a multidimensional analysis of voice
production in the irradiated population. To paint a holistic picture of voice problems in the
irradiated population, we performed a detailed voice assessment battery in adults irradiated for
laryngeal cancers. This stage further helped highlight physiological and psychosocial issues as a
result of disordered voice production in this population since multiple dimensions of voice
production were affected as a result of radiation toxicity in our study population.
Stage 3: Stage 3 focused on the rehabilitation of physiological and psychosocial issues identified
in Stage 2 by implementing a systematic prescriptive evidence-based voice therapy program
(Vocal Function Exercises) in adults irradiated for laryngeal cancers. Presently there is a dearth of
evidence in the field of voice rehabilitation following radiation therapy (XRT) for laryngeal
cancers. This stage was designed as a Phase 2 clinical trial to investigate the efficacy of the VFE
program in the current study population with the intent of collecting preliminary (pilot) data to
justify a larger multicenter clinical trial. A VFE + vocal hygiene group was compared to vocal
hygiene counseling in isolation, which has been the most commonly used intervention method for
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voice rehabilitation in this population. Based on our preliminary data, VFEs appear to be a
promising voice therapy method for exploration in the treatment of voice problems following
radiation therapy (XRT) when compared to vocal hygiene alone (VH).
The following section summarizes and discusses findings from all three study stages.
Stage 1 of the dissertation study highlighted the head and neck cancer burden in
Kentucky, with a focus on trends in Appalachian Kentucky. A larger proportion of patients
diagnosed and/or treated at UK belonged to Appalachian Kentucky as compared to urban
Kentucky. Within urban and Appalachian Kentucky, a larger number of patients were diagnosed
with advanced stage HNC during the specified study period (January 1, 2008 to December 31,
2010). Advanced HNCs are often treated with multiple modalities which can be a combination of
surgery and/or radiation therapy and/or chemotherapy. Each of these modalities by themselves is
associated with treatment-related morbidity. Consequently, a combination of multiple modalities
further intensifies treatment-related morbidity. The need for multi-modality treatment also adds
to the cost burden. High levels of treatment-related morbidity coupled with a significant cost
burden can have negative effects on an individual’s overall quality of life and can hamper overall
recovery after treatment. The cost burden is especially significant for patients in Appalachian
Kentucky since 54 Appalachian counties of Kentucky have socioeconomic status factors which
are the poorest among all Appalachian regions of the United States. 167,171,180 In addition, patients
treated for advanced HNCs often require long-term voice and swallowing rehabilitation.45 The
issue of requiring long-term voice and swallowing rehabilitation is further compounded by the
limited access to medical facilities in these geographic regions 166,167,172,173 which can result in
this population remaining largely underserved. To alleviate the issue of healthcare access and
costs, outreach programs that focus on prevention through education, and early identification
through screening for HNCs can be implemented. Early diagnosis and intervention of HNC
reduces the need for multimodality treatment, improves treatment outcomes, and can
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consequently reduce treatment costs. To this end, we plan to implement outreach programs with a
focus on education, screening and prevention of HNCs in the identified high-risk counties in
Appalachian Kentucky. While steps are yet to be taken to address issues related to late diagnosis
in Kentucky, there is a large population of patients that have been treated for HNCs who require
subsequent long-term voice and swallowing rehabilitation. As a result, voice and swallowing
rehabilitation following treatment for HNCs is an issue that requires special attention in
Kentucky. For the present dissertation, our focus was on voice rehabilitation following XRT for
laryngeal cancers. In the current sample the most commonly diagnosed HNC site was laryngeal
cancer and a majority of these patients were treated with XRT. Therefore, we can expect to see a
large proportion of patients with long-term voice problems as a result of post-radiation sequelae.
The next section describes stage 2 of the study which was aimed at characterizing vocal function
in adults previously irradiated for laryngeal cancers.
As established in previous chapters, voice production is negatively affected as a result of
XRT. Stage 2 presented the reader with a holistic picture of physiological and psychosocial
changes in voice production that occur as a result of XRT. This study stage also compared the RT
(radiation therapy group) group’s voice production characteristics to a control group of
individuals who were matched in terms of age, sex and pack years of smoking. Data from 18
participants (RT=10, control=8) were included for final analysis. The RT group consisted of one
patient that had a history of advanced laryngeal cancer and 9 patients with a history of early
glottic cancer. The participant with advanced laryngeal cancer was the only participant who had
received adjuvant chemotherapy as part of treatment. For the first time, the voice assessment
battery consisted of a detailed assessment protocol which included all five domains of voice
assessment. These domains encompass the physiological and psychosocial factors of voice
production. The study demonstrated that voice production in the RT group was significantly more
disordered across all five domains of voice assessment as compared to the control group. These
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findings in the RT group also reiterated the long term deficits in vocal function as a result of XRT
11,17,45

since the time of completion from treatment was 24-84 months. None of the participants in

the RT group showed normal clinical values across all five domains of voice assessment. Our
study findings were consistent with previous study findings which have investigated the effects of
XRT on voice quality. These changes are not only seen in parameters of voice production, but
also at the level of laryngeal tissues and intrinsic laryngeal muscles.31,129 Studies by Tedla et.al
and Johns, et.al both demonstrated long term changes in intrinsic laryngeal muscles which were
characterized by reorganization of muscle fibrils and increased deposition of collagen. 31,129 The
study by Johns et.al. also showed an increase in fibronectin levels in the superficial layer of the
lamina propria. All of these findings would translate into reduced pliability of the vocal fold
tissues. 31 These changes were reflected in the stroboscopic and high speed laryngeal parameters
in the present RT group since a larger proportion of participants demonstrated abnormal vocal
fold vibratory characteristics as compared to the control group. In addition, 80% of participants in
the RT group were judged as having abnormal vocal fold findings such as erythema, edema and
increased vascularity. Disruption in voice production was also reflected in the patient self
assessment, auditory perceptual, acoustic and aerodynamic measures. Participants in the RT
group demonstrated a higher score on the VHI which reflects a greater voice handicap. The scores
in the physical domain of the VHI were affected the greatest. Individuals scored themselves high
on items that were related to the voice sounding creaky, breathy, or dry. These changes perceived
by participants were reflected in increased auditory-perceptual ratings of roughness, breathiness,
and strain on the CAPE-V. These auditory-perceptual ratings were further reflected in the
acoustic and aerodynamic findings in the RT group. Perturbation and noise measures were higher
in the RT group, however these measures were not statistically significant. The aerodynamic
measure that was significantly different between the two groups was Psub. The increase in PSub
levels is indicative of the increased stiffness and decreased pliability observed in vocal fold
tissues. These findings are consistent with laryngeal findings in the present study group since the
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majority of participants in the RT group showed vocal fold edema and decreased pliability of the
vocal folds (100% showed a reduced amplitude of vibration and 90% showed a reduced mucosal
wave). The entire sample in the RT group also demonstrated laryngeal hyperfunction which is an
indicator of faulty compensatory patterns resulting from sensory and motor feedback changes in
the laryngeal mechanism. This stage of the study further strengthened previous study findings of
long term, and in some cases permanent deleterious voice changes as a result of XRT. Despite the
fact that these changes in voice production are well established, currently, there is no standardized
treatment to the rehabilitation for voice problems in this population.
The next stage, stage 3 of the study investigated the efficacy of a well-researched,
prescriptive voice therapy approach in improving vocal function in adults irradiated for laryngeal
cancers. This stage of the study was aimed at investigating a standardized treatment protocol for
this population. The following section summarizes results from stage 3 of the dissertation.
The focus of Stage 3 was on investigating the efficacy of Vocal Function Exercises
(VFE) in improving vocal function in adults irradiated for laryngeal cancers. VFEs are a set of
laryngeal manipulations which are aimed at strengthening and rebalancing the three subsystems
of voice production.21 This exercise program is highly prescriptive and allows for easy plotting of
progress through the course of voice therapy. To date, there are 23 peer-reviewed studies which
have demonstrated the efficacy of VFEs in elite voice users, normal voices, pathological voice
disorders and individuals over the age of 60 years. 18,19,22,35,36,69,87,88,91,101-114 However, the efficacy
of VFEs utilized with patients irradiated for laryngeal cancers has never been studied. Previous
studies that investigated voice rehabilitation subsequent to XRT have demonstrated an
improvement in voice related quality of life and auditory-perceptual measures. However, none of
these studies have specified their intervention methods. Central to treatment approaches across
these studies has been vocal hygiene counseling. 13-16 To this end, the present study compared the
efficacy of VFEs to vocal hygiene (VH) in improving vocal function in the current study
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population. Participants were randomized to either the VFE+VH group or the VH group. The
intervention period was 6 weeks. The primary end point for our study was improvement in VHI
scores and secondary end-points included improvements in auditory-perceptual, acoustic,
aerodynamic, stroboscopic and high speed measures. These parameters were selected based on
the five domains of voice assessment. Study findings demonstrated an overall statistically
significant improvement in patient self-assessment and select auditory perceptual measures.
These results were consistent with previous study findings from Van Gogh, et.al,15,16 Tuomi
et.al.,14 and Bergstorm, et.al.13 Select stroboscopic and high speed measures also improved in the
VFE+VH group. Though select parameters in the VH group improved as well, none of the
parameters were statistically significant at p=0.1.
We also performed a detailed analysis by participant in each group. We analyzed the
number of participants who improved across all five domains in both groups. Fifty percent of
participants in the VFE+VH group demonstrated an improvement across all five domains. Zero
percent of participants in the VH group showed improvement across all five domains.
Interestingly, the three participants in the VFE+VH groups who showed the best adherence to the
full VFE protocol showed an improvement in all five domains of voice assessment. This is
consistent with previous study findings by Nguyen, et.al106 which demonstrated that participants
who performed the full VFE protocol showed the greatest improvement in voice parameters when
compared to those who completed a partial VFE protocol. However, the VH group also showed
an improvement in some, if not all study parameters. Therefore the use of VH with the current
population cannot be discounted. These improvements in the VFE+VH group support previous
study findings which have demonstrated that VH is more effective when coupled with a more
physiologic voice therapy approach such as VFE.18-20 These study findings support the utility of
preliminary use of VFEs in this population.
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Each of the above study stages had discrete study aims and hypotheses which are
described below. In addition, the next section informs the reader on the acceptance or rejection of
study hypotheses with respect to each dissertation stage.
Specific aims and Hypotheses
Stage 1
Study title: Addressing the head and neck cancer burden in Appalachian Kentucky: A single
center experience
Specific aim 1: To characterize the distribution of head and neck cancers in the treatment-seeking
population at the University of Kentucky Markey Cancer Center in terms of site, stage, treatment
trends, tobacco use and basic demographics in patients who sought treatment from January 2008
to December 2010.
Hypothesis: Specific aim 1 was purely observational and did not operate on a specific hypothesis
Specific aim 2: To compare the distribution of head and neck cancers across Appalachian and
non-Appalachian counties. Given the higher rate of tobacco use in Appalachian in comparison to
non-Appalachian counties, we hypothesized that a larger number of patients identified at UK
would belong to Appalachian counties.
Hypothesis for specific aim 2 was accepted since a larger proportion of patients seen between
2008 and 2010 belonged to Appalachian counties (n=278) as compared to non- Appalachian
counties (n=198).
Specific aim 3: To compare stage of cancer at the time of detection across Appalachian and nonAppalachian counties. Considering the limited access to medical facilities faced by the
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Appalachian population, 167 we hypothesized that the Appalachian population would have more
advanced stage cancers at the their initial visit.
Hypothesis for specific aim 3 was rejected because although a larger number of patients within
Appalachian Kentucky were diagnosed with advanced stage HNC, proportionally nonAppalachian Kentucky showed a higher proportion of patients diagnosed with advanced stage
HNC.
Stage 2
Study title: A study of vocal function using a multi-dimensional assessment battery in adults
irradiated for laryngeal cancer
Specific aim 1: To characterize vocal function in subjects who have been treated with radiation
therapy for laryngeal cancers as determined by stroboscopic imaging, high-speed digital laryngeal
imaging, acoustic, aerodynamic, and perceptual analyses and, patient self-report measures.
Previous studies have reported deterioration of select parameters within all of the above domains
of voice assessment after completion of radiation therapy. We hypothesized that the present study
would follow similar trends.187,188
Hypothesis for specific aim 1 was accepted since study participants in the RT group demonstrated
clinically worse values on select parameters in all five domains of voice assessment as compared
to the control group.
Specific aim 2: To compare vocal function in individuals who have been treated with radiation
therapy with age, sex and pack-years matched controls as determined by stroboscopic imaging,
high-speed laryngeal imaging, acoustic, aerodynamic, perceptual and patient self-report
measures. Previous studies have reported deterioration in vocal function after radiation
therapy.1,12,77,193,200 However, factors such as tobacco smoking and age-related changes have been

80

known to affect vocal function adversely as well.194,195 In an attempt to use matched controls, we
matched subjects in the control group based on age, sex and tobacco use. We hypothesized that
the present study would show clinically worse values of vocal function in the irradiated group as
compared to the control group.
Hypothesis for specific aim 2 was accepted because statistically significant differences were
observed between select parameters of the five domains of domains of voice assessment between
the RT and control groups with the RT group demonstrating worse clinical values of vocal
function.
Stage 3
Study title: Investigating the efficacy of Vocal Function Exercises in improving vocal function in
adults irradiated for laryngeal cancers
Specific aim 1: To investigate the efficacy of Vocal Function Exercises (VFE) for improving
voice production in adults irradiated for larynx cancers as demonstrated by change in pre- and
post-intervention Voice Handicap Index scores. The present stage was designed as a Phase 2
clinical trial with Voice Handicap Index being the primary outcome measure. Secondary outcome
measures include laryngeal stroboscopy, high-speed laryngeal imaging, acoustic analysis,
aerodynamic analysis and auditory-perceptual measures. We hypothesized that the VFE + VH
group will demonstrate significantly greater improvement in pre- and post-treatment Voice
Handicap measures as compared to the VH only group.
The hypothesis for specific aim 1 was accepted since a statistically significant change was seen in
the VFE+VH group for the physical domain of the Voice Handicap Index for pre to post
treatment measures at p<0.1. The VH group did not show statistically significant changes for any
domains of VHI for pre to post treatment measures.
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Specific aim 2: To investigate the efficacy of Vocal Function Exercises (VFE) for improving
voice production in adults irradiated for larynx cancers as demonstrated by improvement in select
parameters from the five domains of voice assessment. Outcome measures from the five domains
of voice assessment include patient self assessment, auditory-perceptual measures, acoustic
analysis, aerodynamic analysis, laryngeal stroboscopy, and high-speed laryngeal imaging. We
hypothesized that the VFE + VH group would demonstrate a larger proportion of participants
with an improvement across all five domains as compared to the VH only group.
The hypothesis for specific aim 2 was accepted since 50% of participants in the VFE+VH group
demonstrated an improvement across select parameters in five domains of voice assessment.
None of the participants in the VH group showed an improvement across all five domains of
voice assessment.
CONCLUSIONS AND FUTURE DIRECTIONS
From the three stages of the present dissertation, we have established the need for
standardized voice rehabilitation programs for patients following XRT. Stage 2 further
strengthened previous study findings that demonstrated the deleterious effects of radiation
therapy on overall vocal function. To this end, stage 3 provides us with preliminary data on the
efficacy of a prescriptive and well-researched voice therapy program, known as Vocal Function
Exercises (VFE) in the current study population. Our preliminary results are promising for the
utility of VFEs in the irradiated population considering the improvement seen in our primary
outcome measure as well as multiple voice parameters. Stage 1 was effective in highlighting the
need for voice rehabilitation in our sample of the Kentucky population, especially Appalachian
Kentucky owing to an observed high proportion of laryngeal cancers and high proportion of
patients being treated with XRT. Stage 1 also highlighted the need for education, prevention and,
screening programs for underserved areas of Appalachian Kentucky to reduce HNC-related
morbidity and mortality, consequently improving survival and quality of life.
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However, these studies were not without limitations which have been described in
chapters 3,4, and 5. Future directions for each of these stages are directly related to study
limitations as well as additional information that needs to be gained from this study population.
Future directions with reference to each stage are described in the following section:
Future directions for Stage 1: It is difficult to generalize the present study findings to the rest of
Kentucky since we focused on a sample from a single center. For further analysis, data from the
whole of Kentucky can be analyzed for the same study parameters. This would help us identify
high risk regions that can be targeted for prevention and screening programs. One of the first
steps to implementing such a program would ideally be collaborating with primary care
physicians in the area. This is in keeping with the colorectal screening program in Kentucky,
which as been so successful partially due to strong collaboration from PCPs in the community
Future directions for Stage 2: Our study was limited in terms of sample size since we were
unsuccessful in accruing the target sample size. In addition, the RT group was not equal in terms
of site and stage since a majority of our participants had a history of early glottic cancers and only
one participant was a history of advanced supraglottic cancer. For future studies, stratification of
RT group by site and stage is suggested. Also, the majority of studies that have investigated vocal
function following XRT have focused on early glottic cancers. It would be interesting to compare
vocal function following irradiation of early and late stage laryngeal cancers. In addition, a
baseline evaluation prior to XRT would be interesting to analyze as well to account for changes
as a result of cancer itself and immediate treatment effects.
Future directions for Stage 3: As previously stated, our study was limited in terms of sample size
since we were unsuccessful in accruing the target sample size. This makes generalization of
results to larger populations difficult. For future studies, accrual of a larger sample size is
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suggested with a larger multicenter clinical trial. Similar to stage 2, participants need to be
stratified by site and stage which would be possible with a larger sample size.
Another drawback of this study was the discrepancy in the contact time with the treating
SLP between each group. For future studies, an improved plan for assessing adherence to VH
needs to be developed. In addition, the VH group should ideally receive the same contact time
with the treating SLP as the VFE+VH group. The next step of this study needs to be extended to a
larger population which should be followed up over a longer period of time. Fifty percent of the
present study participants in the VFE+VH group demonstrated an improvement in all five
domains of voice assessment, however whether these improvements can be maintained given the
delayed nature of XRT is uncertain. Ideally participants need to be followed for up to 12 months
to investigate whether these initial improvements in vocal function as a result of VFE+VH are
maintained.
The present study investigated the efficacy of VFE in adults who had completed XRT at
least 6 months prior to study recruitment. Prophylactic swallowing exercises have been
demonstrated to be efficacious in the alleviation of swallowing problems secondary to XRT.201,202
Similarly, it would be interesting to investigate if implementation of VFE during XRT alleviates
the severity of voice problems that occur after XRT.
The effectiveness of exercise on the irradiated larynx also should also be assessed at the
level of laryngeal tissues (intrinsic laryngeal muscles, vocal fold mucosa and laryngeal mucosa,
laryngeal cartilage) to investigate if behavioral changes seen in voice parameters are in fact being
engendered as changes at the structural level. This investigation can be accomplished by
implementing an animal study where irradiated larynges are exposed to fictive exercise.
Subsequently, these exercised tissues can be studied in detail to document structural or cellular
improvements.
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Summary
These studies demonstrate that Kentuckians suffer with a disproportionately high
incidence of head and neck cancers. Radiation treatment for laryngeal cancer has significant and
long-lasting physiological and psychosocial effects on voice production which significantly affect
quality of life. Vocal Function Exercises may provide a promising intervention approach for
improving disordered voice production caused by the toxic effects of XRT. These studies lay the
groundwork for meaningful future studies aimed at prevention and treatment of this life altering
disorder.
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TABLES: CHAPTER 3
Table 3.1: Site of primary lesion (n=476). Appalachian versus non- Appalachian
Site of lesion
Larynx
Tongue
Esophagus
Oropharynx
Gum and hard palate
Floor of mouth
Hypopharynx
Buccal mucosa
Nasopharynx
Lip
Salivary gland
Tonsil
Total
distribution

Appalachian
83
46
37
2
21
19
15
2
8
6
10
29
278

Non-Appalachian
47
41
30
1
19
10
9
2
3
2
7
27
198

Table 3.2: Percentage of tobacco users (n=475, 1 missing), Appalachian versus nonAppalachian distribution
Type of tobacco use
Cigarette smokers
Never smokers/non- smokers
Mixed use: Smoking+ smokeless tobacco
Smokeless tobacco
Cigar/ pipe
Not recorded
Total

Appalachian
190
33
6
6
2
40
277
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Non-Appalachian
129
32
4
3
4
26
198

Table 3.3. Primary treatments administered (n=476), Appalachian versus non- Appalachian
distribution
Treatment modality
Chemotherapy (CT) + Radiation therapy (RT)
Surgery
Surgery + Chemotherapy+ Radiation therapy
Surgery + Radiation therapy
Radiation therapy
No definitive treatment
Chemotherapy
Surgery + Chemotherapy
Radiation therapy + Chemotherapy + other
treatment
Total

Appalachian
69
72
62
34
15
20
4
1
1

Non-Appalachian
60
37
46
24
20
9
2
0
0

278

198

Table 3.4: Disease stage at the time of diagnosis (n=476), Appalachian versus nonAppalachian distribution
Stage
Stage 0
Stage I
Stage II
Stage III
Stage IV
Unknown
Total

Appalachian
8
50
42
46
114
18
278

Non-Appalachian
1
25
24
46
89
13
198

Table 3.5: Results from Fisher’s exact test comparing early versus late stage cancers
between Appalachian and non- Appalachian regions
Counties
Appalachian
Non- Appalachian
Early (Stage 0, I , II) 100 (38.4%)
50 (27%)
Late (Stage III- IV)
160 (61.5%)
135 (72.9%)
Total
260
185
(*Fisher’s exact test p-value, indicates significance at p<0.05)
Stage

Significance 2- sided
(p<0.05)
0.014*

Table 3.6: Results from Fisher’s exact test comparing single versus multimodality
treatments in Appalachian and non- Appalachian regions
Treatment

Appalachian
Single modality
111 (39%)
Multi-modality
167 (60%)
Total
278
(*Fisher’s exact test p-value)

Counties
Non- Appalachian
68 (34%)
130 (65%)
198
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Significance 2- sided
(p<0.05)
0.249

TABLES: CHAPTER 4
Table 4.1: Five domains of voice assessment with select assessment parameters
Assessment
Domain

Test tool

Measures

Auditory
perceptual

Consensus Auditory
Perceptual
Evaluation – Voice
(CAPE-V)

Patient selfassessment

Voice Handicap
Index (VHI)

Overall severity, roughness,
breathiness rating (100 mm
Visual Analog Scale) on the
rainbow passage
Total score, physical domain,
emotional domain and
functional domain
Jitter (%)
Shimmer (dB)
Noise-to-harmonics ratio
(NHR)
Pitch range
Maximum phonation time
(MPT)
CSID /a/
CSID – easy onset
sentence(EOS)
CSID – all voiced sentence
(AVS)
CSID – hard glottal attack
sentence (HGAS)
CSID – voiceless plosive
sentence
Mean airflow rate (L/s)
Subglottal pressure (Psub) (cm
H2O)
Laryngeal airway resistance
(LAR) (cm H2O/L/s)
Phonation threshold pressure
(PTP) (cm H2O)
Glottic closure (GC), mucosal
wave (MW), amplitude of
vibration (AMP), phase
symmetry (PS), overall
appearance and appearance of
vocal folds

Acoustic

Aerodynamic

Visual
imaging

KayPentax®
Computerized
Speech Laboratory

KayPentax®
Phonatory
Aerodynamics
System

Laryngeal
stroboscopy and
high speed laryngeal
imaging
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Normative values
<10 for each parameter and
overall severity

<10 on each domain
<30 for total score
Jitter <1%
Shimmer <0.35dB
NHR< 0.194
Pitch range: variable
MPT: variable (dependent on
individual’s lung capacity)
CSID /a/ -4.5 to 14
CSID EOS -10.85 to 21.08
CSID AVS -12.4 to 14.4
CSID HGAS -8 to 19.6
CSID VPS -0.6 to 29.2

Airflow rate : 0.08 to 0.2
Psub : 5-8 cmH20
LAR : 30 to 60
PTP: 3-5

GC: 0- complete, 1insufficiency noted, 2incomplete
MW and AMP: 0- normal, 1reduced, 2-absent
PS: 0 – symmetric, 1asymmetric
Overall appearance: 0-normal,
1-abnormal and qualitative
description
Appearance of vocal folds:
Qualitative description

Table 4.2: Participant demographics (n=18) for study 2

Characteristics

Number of participants
Radiation therapy (RT), n=10 Control, n=8

Fisher’s
exact

Sex
Male
Female

7
3

6
2

0.618

66.1
12.96

55.5
13.8

8
1
1

N/A
N/A
N/A

N/A

2
6
2

1
3
4

0.618

37.92 (38.9)

41.38 (23.62)

Age
Mean (age in years)
Standard deviation
Stage (TNM stage)
T1N0M0
T2N0M0
T2N2
Smoking status
Never
Former
Current
Pack years (mean and SD)
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Table 4.3: CAPE-V findings (means and standard deviations by group)
Parameter
Group
CAPE- V overall
severity

Control
RT

CAPE- V pitch

Control
RT

CAPE- V loudness

Control
RT

CAPE- V breathiness

Control
RT

CAPE-V roughness

Control
RT

CAPE- V strain

Control
RT

Mean

Std.
Deviation

8

11.25

12.748

10

29.40

13.745

8

1.25

3.536

10

3.00

4.830

8

7.50

11.339

10

29.90

19.186

8

5.63

9.039

10

32.00

12.419

8

11.25

12.748

10

31.70

15.485

8

11.88

14.377

10

36.10

12.714
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Table 4.4: CAPE- V comparisons – Parametric tests (Independent sample t-tests)
Parameter

t

df

Significance

CAPE-V overall severity

-2.873

16

.011*

CAPE-V breathiness

-5.024

16

.000*

CAPE- V roughness

-3.004

16

.008*

(* indicates significance at p=0.05)

Table 4.5: CAPE – V comparisons – non parametric tests (Mann-Whitney U test)
Parameter

Group
Median
(n=18)
CAPE-V pitch Control (n=8) 0
0
RT (n=10)
CAPE-V
Control (n=8) 0
35
loudness
RT (n=10)
CAPE- V
Control (n=8) 5
35
strain
RT (n=10)
(* indicates significance at p=0.05)

Range
0-10
0-10
0-25
0-57
0-35
20-57
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Std. error of
mean
1.25
1.528
4.01
6.067
5.08
4.021

p-value
0.388
0.012*
0.007*

Table 4.6: Voice Handicap Index (VHI) (means and standard deviations by group)
Parameter

Group

VHI total score

Control

n

Mean

Radiation
VHI -Physical

Control
Radiation

VHI-Functional

Control
Radiation

VHI-Emotional

Control
Radiation

Std. Deviation

8

11.63

12.682

10

22.60

13.501

8

4.88

4.673

10

13.30

9.476

8

4.38

5.290

10

6.60

4.926

8

2.38

3.777

10

2.60

3.596

Table 4.7: VHI comparisons – Parametric tests (Independent sample t-tests)
Parameter

t

df

Significance

VHI total

-1.760

16

0.098

VHI -Physical

-2.292

16

0.036*

(* indicates significance at p=0.05)
Table 4.8: VHI comparisons – non-parametric tests (Mann-Whitney U tests)
Parameter

Group

Median

Range

VHIFunctional
VHIEmotional

Control (n=8)
RT (n=10)
Control
RT

3
6.5
1
1

0-13
0-16
0-11
0-11
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Std.error of
mean
1.87
1.56
1.33
1.13

p- value
0.302
0.812

Table 4.9: Acoustic analyses (means and standard deviations by group)
Parameter
Jitter

Group

n

Control
RT

Shimmer

Control
RT

NHR

Control
RT

MPT

Control
RT

Pitch range

Control
RT

CSID /a/

Control
RT

CSID EOS

Control
RT

CSID AVS

Control
RT

CSID VPS

Control
RT

CSID HGAS

Control
RT
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Mean

Std. Deviation

8

1.095

.99

10

2.141

2.61

8

0.353

.20

10

0.683

.87

8

0.159

.051

10

0.209

.21

8

18.82

4.40

10

15.03

8.9

8

378.21

150.6

10

225.54

128.7

8

12.84

10.92

10

23.79

21.72

8

11

14.93

10

18.62

19.13

8

2.97

10.88

10

8.62

20.39

8

16.47

10.99

10

19.4358

14.10456

8

8.8349

8.76605

10

19.5928

29.28840

Table 4.10: Acoustic analysis – Parametric tests (Independent sample t-tests)
Parameter

t

df

Significance

Shimmer

-.912

15

.376

Pitch range

2.118

13

.045*

-1.286

15

.218

CSID EOS

-.906

15

.379

CSID AVS

-.697

15

.496

CSID VPS

-.478

15

.639

CSID HGAS

-.997

15

.335

CSID a

(* indicates significance at p=0.05)
Table 4.11: Acoustic analysis – Non-parametric tests (Mann-Whitney U test)
Parameter
Jitter
NHR
MPT

Group
(n=18)
Control (n=8)
RT (n=10)
Control (n=8)
RT (n=10)
Control (n=8)
RT (n=10)

Median

Range

0.678

0.376-2.82
0.52-8.76
0.104-0.275
0.121-0.77
14-8-28.7
1.86-29.54

1.342

0.146
0.134

17.29
13.94
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Std. error of
mean
0.351
0.781
0.0183
0.064
1.55
2.74

p-value
0.248
0.563
0.286

Table 4.12: Aerodynamic analysis (means and standard deviations by group)
Parameter

Group

n

Mean

Standard
deviation

Psub

Control

8

6.03

1.73

10

9.08

2.41

8

0.205

0.29

10

.196

0.12

8

60.04

31.74

10

74.69

84.71

8

3.56

1.59

10

5.93

3.25

RT
Mean airflow rate

Control
RT

LAR

Control
RT

PTP

Control
RT

Table 4.13: Aerodynamic analysis – Parametric tests (Independent sample t-tests)
Parameter

t

df

Significance

Psub

-2.952

15

.010*

LAR

-.460

15

.652

PTP

-1.844

14

.086

(* indicates significance at p=0.05)
Table 4.14: Aerodynamic analysis – Non-parametric tests (Mann Whitney U test)
Parameter

Group

Median

Range

Airflow rate

Control (n=8)
RT (n=10)

0.115
0.215

0.04-0.17
0.02-0.43
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Std. error
of mean
0.015
0.036

p-value
0.214

Table 4.15: Stroboscopic parameters (percentage of patients with abnormal stroboscopic
findings)
Parameter

Control (n=8)

RT (n=10)

Glottic closure

2 (25%)

4 (40%)

Mucosal wave

4 (50%)

9 (90%)

Amplitude

3 (37.5%)

10 (100%)

Hyperfunction

8 (100%)

10 (100%)

Overall appearance

3 (37.5%)

7 (70%)

Phase symmetry

2 (25%)

7 (70%)

VF appearance

3 (37.5%)

8 (80%)

Table 4.16: Stroboscopic parameters (Fisher’s exact test)
Parameter

Significance

Glottic closure

0.437

Mucosal wave

0.239

Amplitude *

0.009*

Hyperfunction

0.236

Phase symmetry

0.07

Overall appearance

0.268

(* indicates significance at p=0.05)
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Table 4.17: High speed (percentage of patients with abnormal high speed findings)
Parameter

Control (n=7)
Missing 1

RT (n=8)
Missing 2

Glottic closure

2 (28.5%)

6 (75%)

Mucosal wave

3 (42.8%)

6 (75%)

Amplitude

2 (28.5%)

1 (12.5%)

Phase symmetry

3 (42.5%)

3 (30%)

Table 4.18: High speed laryngeal imaging parameters (Fisher’s exact test)

Parameter

Significance

Glottic closure

0.073

Mucosal wave

0.348

Amplitude

0.194

Phase symmetry

0.622
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TABLES: CHAPTER 5
Table 5.1: Participant demographics by group for study 3 (n=10)
Characteristics
VH=4

Number of participants
VFE+VH, n=6

Fisher’s exact

Sex
Male
Female

4
0

3
3

0.164

57.5
14.2

0.199

Stage (TNM stage)
T1N0M0 3
T2N0M0 1
T2N2 0
T3N0M0 0

3
0
2
1

0.167

Treatment type
Narrow field XRT 4
Wide field XRT 0
Chemotherapy+XRT 0

3
3
3

0.167

0
2
2

5
0
1

0.335

70 (43.97)

33.5 (40.25)

0.11

Age
Mean (age in years) 69
Standard deviation 5.34

Smoking status
Never
Current
Former
Mean pack years (SD)

Table 5.2: Participant attendance and adherence to the VFE protocol
Participant

Session type

1
2
3
4
5
6

In person
In person
Distance
Distance
Distance
In person

Percentage of
sessions
attended
100% (6/6)
100% (6/6)
66.6% (4/6)
50% (3/6)
66.6% (4/6)
66.6% (4/6)

Performed full VFE
protocol twice a day
(2x2)
X
X

Performed full VFE
protocol once a day (2x1)

X
X
X
X

98

Table 5.3: Voice Handicap Index (VHI) Paired t-test: VFE+VH group
Parameter

Mean

Pre VHI total
39.50
Post VHI total
32.50
Pre VHI Physical
19.83
Post VHI Physical
15.67
Pre VHI Functional
12.00
Post VHI Functional
11.33
(*Indicates significance at p= 0.1)

Standard
deviation
19.807
23.020
6.401
8.524
6.356
10.172

t

df

Significance

1.38

5

0.224

2.97

5

0.031*

0.32

5

0.761

t

df

Significance

.577

3

0.604

1.268

3

0.294

.241

3

0.825

Table 5.4: Voice Handicap Index (VHI) Paired t-test: VH group
Parameter

Mean

Pre VHI total

26.00

Standard
deviation
18.779

Post VHI total

19.75

16.879

Pre VHI Physical

15.25

10.308

Post VHI Physical

11.00

8.287

Pre VHI Functional

7.00

8.083

Post VHI Functional

5.75

4.349

Table 5.5: Voice Handicap Index (VHI) Wilcoxon sign test: VFE+VH group
Parameter

Group (n=6)

Median

Range

VHI-Emotional

Pre
Post

2.5
4

0-31
0-14

Std. error
of mean
4.84
2.419

p-value
0.892

Table 5.6: Voice Handicap Index (VHI) Wilcoxon sign test: VH group
Parameter

Group (n=4)

Median

Range

VHI-Emotional

Pre
Post

2.5
0.5

0-9
0-11
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Std. error
of mean
2.179
2.67

p-value
0.655

Table 5.7: Auditory-perceptual measures (CAPE-V scores) for VFE+VH group (Paired ttests)
Parameter

Mean

Pre CAPE-V overall severity

34.83

Standard
deviation
30.499

Post CAPE-V overall severity

25.50

26.898

Pre CAPE-V breathiness

10.17

11.462

Post CAPE-V breathiness

7.00

9.879

Pre CAPE-V roughness

32.50

28.933

Post CAPE-V roughness

18.33

21.248

t

df

Significance

2.025

5

0.099*

1.663

5

0.157

1.963

5

0.107

(*Indicates significance at p= 0.1)
Table 5.8: Auditory-perceptual measures (CAPE-V scores) for VFE+VH group (Wilcoxon
sign tests
Parameter

Group (n=6)

Median

Range

CAPE-V pitch

Pre
Post
Pre
Post
Pre
Post

6.5

2-25
0-25
0-10
0-10
2-45
0-42

CAPE-V
loudness
CAPE- V
strain

7.5

1
0

40.85
8.5

100

Std. error of
mean
4.088
3.069
1.585
1.633
8.68
6.87

p-value
0.715
0.317
0.116

Table 5.9: Auditory-perceptual measures (CAPE-V scores) for VH group (Paired t-tests)
Parameter

Mean

Pre CAPE-V overall severity

40.75

Standard
deviation
34.277

Post CAPE-V overall severity

25.75

14.431

Pre CAPE-V pitch

18.00

22.405

Post CAPE-V pitch

14.25

15.435

Pre CAPE-V roughness

46.25

33.049

Post CAPE-V roughness

20.00

19.131

Pre CAPE-V strain

33.75

27.789

Post CAPE-V strain

20.25

16.899

t

df

Significance

1.414

3

0.252

.994

3

0.393

1.733

3

0.181

2.089

3

0.128

(*Indicates significance at p=0.1)
Table 5.10: Auditory-perceptual measures (CAPE-V scores) for VH group (Wilcoxon sign
tests)
Parameter
CAPE-V
loudness
CAPE-V
breathiness

Group
(n=4)
Pre
Post
Pre
Post

Median

Range

2
2.5
4
10

2-10
0-10
2-50
3-35
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Std.error of
mean
2
2.17
11.68
7.32

p- value
0.655
0.655

Table 5.11: Acoustic measures for VFE+VH group (Paired t-tests)
Parameter

Mean

Pre jitter
2.55
Post jitter
2.24
Pre MPT
15.03
Post MPT
20.15
Pre pitch range
290.05
Post pitch range
565.47
Pre CSID /a/
36.921
Post CSID /a/
30.237
Pre CSID EOS
25.66
Post CSID EOS
30.07
Pre CSID AVS
20
Post CSID AVS
16.07
Pre CSID VPS
30.86
Post CSID VPS
24.71
Pre CSID HGAS
31.81
Post CSID HGAS
27.51
(*Indicates significance at p=0.1)

Standard
deviation
1.43
1.58
5.76
8.70
260.79
126.21
27.47
28.635
25.56
18.59
30.83
27.73
27.17
17.58
36.69
29.96

t

df

Significance

.506

5

0.634

-3.269

5

0.022*

-4.370

4

0.012*

.728

4

0.507

-.813

5

0.453

.979

5

0.373

1.17

5

0.295

1.270

5

0.260

Table 5.12: Acoustic measures for VFE+VH (Wilcoxon sign tests)
Parameter
Shimmer
NHR

Group
(n=6)
Pre
Post
Pre
Post

Median

Range

0.55
0.384
0.139
0.14

0.322-1.21
0.181-1.23
0.108-0.401
0.113-0.276
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Std.error of
mean
0.133
0.191
0.447
0.307

p- value
0.463
0.6

Table 5.13: Acoustic measures for VH group (Paired t-tests)
Parameter

Mean

Pre jitter
Post jitter
Pre shimmer
Post shimmer
Pre NHR
Post NHR
Pre MPT
Post MPT
Pre pitch range
Post pitch range
Pre CSID EOS
Post CSID EOS
Pre CSID AVS
Post CSID AVS
Pre CSID VPS
Post CSID VPS
Pre CSID HGAS
Post CSID HGAS

3.77
1.95
1.56
0.67
0.38
0.17
10.08
16.04
222.15
283.9
28.32
19.11
24.85
11.68
23.67
8.67
34.58
8.67

Standard
deviation
3.61
.93
1.41
0.43
0.31
0.050
9.38
2.56
197.56
263.96
7.03
10.28
25.42
8.62
7.33
17.18
22.46
17.18

t

df

Significance

.875

3

0.446

1.333

3

0.275

1.288

3

0.288

-1.328

3

0.276

-1.697

3

0.188

1.581

3

0.212

1.129

3

0.341

1.479

3

0.236

1.340

3

0.273

Table 5.14: Acoustic measures for VH group (Wilcoxon sign tests)
Parameter

Group (n=4)

Median

Range

CSID-AVS

Pre
Post

21.73
15.17

-0.833-56.79
-1.14-17.53
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Std. error
of mean
12.71
4.31

p-value
0.465

Table 5.15: Aerodynamic measures for VFE+VH group (Paired t-tests)
Parameter

Mean

Pre Psub

11.59

Standard
deviation
3.66

Post Psub

14.07

1.63

Pre phonation threshold
pressure

8.18

2.67

Post phonation
threshold pressure

6.71

2.22

t

df

Significance

-2.112

5

.088*

.891

5

.414

(*Indicates significance at p=0.1)
Table 5.16: Aerodynamic measures for VFE+VH group (Wilcoxon sign tests)
Parameter
Airflow rate
Laryngeal
airway
resistance

Group
(n=6)
Pre
Post
Pre
Post

Median

Range

0.26
0.325
40.27
41.18

0.14-0.43
0.08-0.39
28.71-61.86
33.09-196.59
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Std.error of
mean
0.038
0.055
5.103
26.15

p- value
1.00
0.463

Table 5.17: Aerodynamic measures for VH group (Paired t-tests)
Parameter

Mean

Pre Psub

8.22

Standard
deviation
2.79

Post Psub

7.66

3.21

Pre airflow rate

0.18

.054

Post airflow rate

0.16

.038

Pre Laryngeal airway
resistance

43.18

11.43

Post Laryngeal airway
resistance

44.19

21.009

Pre phonation threshold
pressure

6.27

1.49

Post phonation
threshold pressure

7.63

5.48
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t

df

Significance

0.456

3

0.679

0.805

3

0.480

-0.081

3

0.941

-0.486

2

0.675

Table 5.18: Pre to post differences for stroboscopic parameters for VFE+VH group
Parameter (n= 4, Missing = 2)

Significance

Glottic closure

0.136

Mucosal wave

0.062*

Amplitude

0.017*

Phase symmetry

0.05*

Hyperfunction

0.329

(Significant at p=0.1)
Table 5.19: Pre to post differences for stroboscopic parameters for VH group
Parameter (n=3, Missing=1)

Significance

Glottic closure

1.00

Mucosal wave

0.513

Amplitude

0.135

Phase symmetry

1.00

Hyperfunction

0.33
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Table 5.20: Pre to post differences for high speed parameters for VFE+VH group
Parameter (n= 4, Missing = 2)

Significance

Glottic closure

0.157

Mucosal wave

0.238

Amplitude

0.062*

Phase symmetry

0.174

(Significant at p=0.1)
Table 5.21: Pre to post differences for high speed parameters for VH group
Parameter (n= 2, Missing = 2)

Significance

Glottic closure

0.5

Mucosal wave

0.33

Amplitude

CNA

Phase symmetry

CNA

(CNA=could not assess due to low sample size)
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Table 5.22: Improvement in domain demonstrated by each study participant
Participant by
Patient
Auditory Acoust
group
self
perceptua ic
(improved
assessme l
analysi
domains/total
nt
s
domains)
VH 1 (4/5)
+
+
VH 2 (3/5)
+
+
+
VH 3 (1/5)
+
VH 4 (3/5)
+
+
+
VFE+VH 1
+
+
+
(5/5)
VFE+ VH 2
+
+
+
(5/5)
VFE+VH 3
+
+
(2/5)
VFE+VH 4
+
+
+
(3/5)
VFE+VH 5
+
+
(3/4)
VFE+VH 6
+
+
+
(5/5)
(+ = improvement, CNA=could not assess)
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Aerodynam
ic analysis

Stroboscopic
assessment

+

+

Highspeed
assessmen
t

+

+

CNA
CNA
+

+

+

+

+

CNA

CNA

+

+

CNA

APPENDIX I: STUDY CHECKLIST
Please circle ‘yes; for each item that has been completed
Subject #:

Informed consent: Yes / No
VHI: Yes / No: Score: Physical: _____ , Functional: _____, Emotional: _____ , Total: _____
CAPE-V: Yes / No
Overall quality
Pitch
Loudness
Breathiness
Acoustics: Yes/No
Fo
Jitter
Shimmer
NHR
Maximum Phonation Time
CSID for /a/
CSID for easy onset sentences
CSID for voiced plosive sentences
CSID for hard glottal attack
sentences
CSID for All voiced sentences
Aerodynamics: Yes/No
Vital capacity
Mean airflow during voicing
Mean peak air pressure
Airway resistance
Phonation threshold pressure

Strobe: Yes/No, Exam: Flexible/Rigid
0= normal / 1= Abnormal
High Speed Laryngeal imaging : Yes/No, if ‘no’ please state reason:_____________________
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APPENDIX II: CAPE-V

From: ASHA. Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)
ASHA Special Interest Division 3, Voice and Voice Disorders. 2009
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APPENDIX III: RAINBOW PASSAGE

The rainbow is a division of white light into many beautiful colors. These take the shape of a long
round arch with it its path high above and its two ends apparently beyond the horizon.
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APPENDIX IV: VOICE HANDICAP INDEX (VHI)

From: The voice handicap index (VHI) development and validation. American Journal of Speech
Language Pathology. 1997;6(3):66-70.
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APPENDIX V: STROBE AND HIGH SPEED RATING FORMS
i) Strobe rating form: Blinded subject ID_____________________
Rater: _______________________
Glottic closure: __________________ (0= complete, 1= insufficient – please identify type of
insufficiency, 2= spindle shaped or incomplete)
Phase symmetry: ___________________ (0= symmetric, 1= asymmetric)

Parameter

Right VF
(0=normal, 1= reduced, 2=
absent, 3= exaggerated)

Left vocal fold
(0=normal, 1= reduced, 2=
absent, 3= exaggerated)

Mucosal wave
Amplitude
Qualitative descriptors of
TVFs (erythema, edema
etc)
Hyperfunction (0=no
hyperfunction,
1=hyperfunction present)
Overall laryngeal
appearance (0=normal,
1=abnormal), description

ii) HSV rating form: Blinded subject ID_____________________
Rater: _______________________
Glottic closure: __________________ (0= complete, 1= insufficient – please identify type of
insufficiency, 2= spindle shaped or incomplete)
Phase symmetry: ___________________ (0= symmetric, 1= asymmetric)
Parameter

Right VF
(0=normal, 1= reduced, 2=
absent, 3= exaggerated)

Mucosal wave
Amplitude
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Left vocal fold
(0=normal, 1= reduced, 2=
absent, 3= exaggerated)

APPENDIX VI: VOCAL HYGIENE INFORMATION SHEET

Voice Conservation & Vocal Hygiene: Tips for a Healthy Voice
Side effects of Radiation therapy: Radiation therapy is an extremely effective and curative
method used in the management of throat cancers. However you may have noticed a number of
side effects through treatment. Many of these side effects occur due to the damage caused to the
salivary glands during the course of radiation. These include:
1) Dryness of the throat and mouth
2) Difficulty swallowing
3) Hoarseness
4) Weight loss and nausea
What is vocal hygiene? The following suggestions are meant to guide you in taking care of your
voice and overcoming and preventing some voice problems. Vocal hygiene is positive change –
suggestions that will make you feel better and make you sound better too!
Drink lots of water: As mentioned one the main issues with radiation therapy is throat and
mouth dryness due to damage to the salivary glands. One of the first steps to minimize dryness
therefore is adequate hydration. The entire voice producing mechanism (mouth, throat, vocal
folds and lungs, too) needs moisture to work efficiently. If you do a lot of talking (on the
telephone, group meetings, one-on-one discussion) or singing, always have water nearby and take
frequent sips. Sometimes, when people are not in the habit of drinking water, they don’t even
realize that they are thirsty until after they begin drinking. And water is good for the health of
your entire body.
Limit Caffeine and Alcohol use: Both Caffeine and alcohol have significant drying effects on
tissues of the mouth and throat. A way to stay well hydrated is to limit use of products that
dehydrate vocal fold and oral structures.
Don’t smoke and completely eliminate tobacco use: Smoking cigarettes, pipes, cigars and other
substances can seriously harm your overall health, and damage the entire respiratory system
including the upper airway, throat, mouth and nose. The heat and inhaled chemicals cause
inflammation, swelling, sometimes irreversible damage, and cancer. The only way to counter the
effects of smoking is to stop.
Eliminate habitual and frequent throat clearing. We all must clear our throats on occasion, but
recognize that when you clear your throat you are “slamming” the vocal folds together hard. This
can damage the vocal folds by causing inflammation and localized irritation. It is common for
people to get into the habit of clearing the throat after radiation therapy due to the dryness they
experience.
Control and limit vocal loudness. Do not speak louder than the situation or environment
demands. Don’t “compete vocally”. Avoid yelling, loud cheering, speaking over loud noises. Use
non-vocal methods to get the attention of others (i.e., clap your hands, raise your arm, blow a
whistle, ring a bell, turn lights on and off). Use amplification in large or noisy places. Don’t try to
“out talk” others by increasing loudness. Be aware of how you use your voice in talking over
music, over the TV, communicating up and down stairs in the home, calling the dog, etc.
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Balance extra vocal demands with voice rest. If you have to give a lecture or you know that
you will be speaking for extended periods of time, try to reduce voice use before and after these
episodes. If you must talk a lot at work, try to reduce the amount of talking outside of work.
Listen more and talk less. If you know that you will be using your voice heavily in the evening
(giving a lecture, talking in a noisy environment), then rest your voice more during the day and
after the evening is over.’
Use caution with medications (over-the-counter and prescription).
Decongestants, allergy medicines and some other drugs tend to release fluid from body tissues,
including the vocal folds. If your doctor has recommended that you take these medicines, you
need to try to counteract their drying effect by increasing your water intake. Ask you doctor if
there are any alternative medicines that don’t have such a drying effect. Certain medications are
also contraindicated after radiation therapy. Please consult your cancer care team before
administering any new medication.
(Adapted from The Voice and Swallowing Institute, New York Eye and Ear infirmary)
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APPENDIX VII: VOCAL FUNCTION EXERCISE LOG SHEET

Vocal Function Exercise Practice Record

From: Stemple J, Glaze L, Klaben B. Clinical Voice Pathology: Theory and Management. 4th ed.
San Diego: Plural Publishing; 2009.
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